idB
stringlengths
19
25
idA
stringlengths
19
25
sentA
stringlengths
24
1.82k
sentB
stringlengths
24
1.43k
type
int64
2
2
words
list
wordsA
list
wordsB
list
keywordsA
list
keywordsB
list
labels
list
probs
list
1099800_15_item7_p31_s0
1099800_14_item7_p31_s0
The $23.4 million decrease in net sales of Critical Care products in 2013 was due primarily to foreign currency exchange rate fluctuations, which decreased net sales by $28.9 million, due primarily to the weakening of the Japanese yen against the United States dollar.
The $16.6 million increase in net sales of Critical Care products in 2014 was due primarily to enhanced surgical recovery products, and core hemodynamic products outside the United States, partially offset by foreign currency exchange rate fluctuations, which decreased net sales by $12.0 million, due primarily to the w...
2
[ "<tag1>", "The", "$", "23.4", "million", "decrease", "in", "net", "sales", "of", "Critical", "Care", "products", "in", "2013", "was", "due", "primarily", "to", "foreign", "currency", "exchange", "rate", "fluctuations", ",", "which", "decreased", "net", "sales"...
[ "The", "$", "23.4", "million", "decrease", "in", "net", "sales", "of", "Critical", "Care", "products", "in", "2013", "was", "due", "primarily", "to", "foreign", "currency", "exchange", "rate", "fluctuations", ",", "which", "decreased", "net", "sales", "by", ...
[ "The", "$", "16.6", "million", "increase", "in", "net", "sales", "of", "Critical", "Care", "products", "in", "2014", "was", "due", "primarily", "to", "enhanced", "surgical", "recovery", "products", ",", "and", "core", "hemodynamic", "products", "outside", "the...
[]
[ "16.6", "increase", "enhanced", "surgical", "recovery", "core", "hemodynamic", "outside", "partially", "offset", "12.0" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_15_item7_p34_s0
1099800_14_item7_p36_s0
The 3.2 percentage point increase in gross profit as a percentage of net sales in 2012 was driven by:
The 1.6 percentage point decrease in gross profit as a percentage of net sales in 2014 was driven by:
2
[ "<tag1>", "The", "3.2", "percentage", "point", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2012", "was", "driven", "by", ":", "<tag2>", "The", "1.6", "percentage", "point", "decrease", "in", "gross", "profit", ...
[ "The", "3.2", "percentage", "point", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2012", "was", "driven", "by", ":" ]
[ "The", "1.6", "percentage", "point", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2014", "was", "driven", "by", ":" ]
[]
[ "1.6", "decrease" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 1, -100, -100, 1, -100, 0, -100, 0, 0, -100, 0, -100, -100, -100, 0, 0, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_15_item7_p49_s0
1099800_14_item7_p53_s0
The loss (gain) on investments in unconsolidated affiliates primarily represents our net share of gains and losses in investments accounted for under the equity method, and realized gains and losses on our available-for-sale and cost method investments.
The loss on investments primarily represents our net share of gains and losses in investments accounted for under the equity method, and realized gains and losses on our available-for-sale and cost method investments.
2
[ "<tag1>", "The", "loss", "(", "gain", ")", "on", "investments", "in", "unconsolidated", "affiliates", "primarily", "represents", "our", "net", "share", "of", "gains", "and", "losses", "in", "investments", "accounted", "for", "under", "the", "equity", "method", ...
[ "The", "loss", "(", "gain", ")", "on", "investments", "in", "unconsolidated", "affiliates", "primarily", "represents", "our", "net", "share", "of", "gains", "and", "losses", "in", "investments", "accounted", "for", "under", "the", "equity", "method", ",", "and...
[ "The", "loss", "on", "investments", "primarily", "represents", "our", "net", "share", "of", "gains", "and", "losses", "in", "investments", "accounted", "for", "under", "the", "equity", "method", ",", "and", "realized", "gains", "and", "losses", "on", "our", ...
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_15_item7_p58_s0
1099800_14_item7_p60_s2
Furthermore, we may later decide to challenge any assessments, if made, and may exercise our right to appeal.
challenge any assessments, if made, and may exercise our right to appeal.
2
[ "<tag1>", "Furthermore", ",", "we", "may", "later", "decide", "to", "challenge", "any", "assessments", ",", "if", "made", ",", "and", "may", "exercise", "our", "right", "to", "appeal", ".", "<tag2>", "challenge", "any", "assessments", ",", "if", "made", ",...
[ "Furthermore", ",", "we", "may", "later", "decide", "to", "challenge", "any", "assessments", ",", "if", "made", ",", "and", "may", "exercise", "our", "right", "to", "appeal", "." ]
[ "challenge", "any", "assessments", ",", "if", "made", ",", "and", "may", "exercise", "our", "right", "to", "appeal", "." ]
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_15_item7_p69_s0
1099800_14_item7_p67_s2
However, we periodically consider various financing alternatives and may, from time to time, seek to take advantage of favorable interest rate environments or other market conditions.
time, seek to take advantage of favorable interest rate environments or other market conditions.
2
[ "<tag1>", "However", ",", "we", "periodically", "consider", "various", "financing", "alternatives", "and", "may", ",", "from", "time", "to", "time", ",", "seek", "to", "take", "advantage", "of", "favorable", "interest", "rate", "environments", "or", "other", "...
[ "However", ",", "we", "periodically", "consider", "various", "financing", "alternatives", "and", "may", ",", "from", "time", "to", "time", ",", "seek", "to", "take", "advantage", "of", "favorable", "interest", "rate", "environments", "or", "other", "market", "...
[ "time", ",", "seek", "to", "take", "advantage", "of", "favorable", "interest", "rate", "environments", "or", "other", "market", "conditions", "." ]
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_15_item7_p8_s5
1099800_14_item7_p6_s5
The following is a summary of important Transcatheter Heart Valve developments during 2013:
The following is a summary of important developments during 2014:
2
[ "<tag1>", "The", "following", "is", "a", "summary", "of", "important", "Transcatheter", "Heart", "Valve", "developments", "during", "2013", ":", "<tag2>", "The", "following", "is", "a", "summary", "of", "important", "developments", "during", "2014", ":", "<tag3>...
[ "The", "following", "is", "a", "summary", "of", "important", "Transcatheter", "Heart", "Valve", "developments", "during", "2013", ":" ]
[ "The", "following", "is", "a", "summary", "of", "important", "developments", "during", "2014", ":" ]
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_15_item7_p71_s2
1099800_14_item7_p70_s0
United States relates to undistributed earnings of certain of our foreign subsidiaries which are considered by us to be indefinitely reinvested.
The majority of cash and cash equivalents and short-term investments held outside the United States relates to undistributed earnings of certain of our foreign subsidiaries, which are considered by us to be indefinitely reinvested.
2
[ "<tag1>", "United", "States", "relates", "to", "undistributed", "earnings", "of", "certain", "of", "our", "foreign", "subsidiaries", "which", "are", "considered", "by", "us", "to", "be", "indefinitely", "reinvested", ".", "<tag2>", "The", "majority", "of", "cash...
[ "United", "States", "relates", "to", "undistributed", "earnings", "of", "certain", "of", "our", "foreign", "subsidiaries", "which", "are", "considered", "by", "us", "to", "be", "indefinitely", "reinvested", "." ]
[ "The", "majority", "of", "cash", "and", "cash", "equivalents", "and", "short", "-", "term", "investments", "held", "outside", "the", "United", "States", "relates", "to", "undistributed", "earnings", "of", "certain", "of", "our", "foreign", "subsidiaries", ",", ...
[]
[ "majority", "cash", "cash", "equivalents", "short", "term", "investments", "held", "outside" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, 1, 0, 1, 0, 1, 1, 0, 1, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, -100, 0, 0, 0, -100, 0,...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_15_item7_p72_s0
1099800_14_item7_p71_s0
We have a Credit Facility which provides up to an aggregate of $750.0 million in borrowings in multiple currencies.
We have a Five-Year Credit Agreement ("the Credit Agreement") which provides up to an aggregate of $750.0 million in borrowings in multiple currencies.
2
[ "<tag1>", "We", "have", "a", "Credit", "Facility", "which", "provides", "up", "to", "an", "aggregate", "of", "$", "750.0", "million", "in", "borrowings", "in", "multiple", "currencies", ".", "<tag2>", "We", "have", "a", "Five", "-", "Year", "Credit", "Agre...
[ "We", "have", "a", "Credit", "Facility", "which", "provides", "up", "to", "an", "aggregate", "of", "$", "750.0", "million", "in", "borrowings", "in", "multiple", "currencies", "." ]
[ "We", "have", "a", "Five", "-", "Year", "Credit", "Agreement", "(", "\"", "the", "Credit", "Agreement", "\"", ")", "which", "provides", "up", "to", "an", "aggregate", "of", "$", "750.0", "million", "in", "borrowings", "in", "multiple", "currencies", "." ]
[]
[ "Five", "Year", "Agreement", "Agreement" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, 0, 0, 1, -100, 1, -100, 1, -100, 0, 0, 0, 1, -100, 0, -100, 0, -100, -100, -100, -100, 0, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p7_s1
1099800_15_item7_p10_s0
We are dedicated to generating robust clinical and economic evidence increasingly expected by patients, clinicians, and payors in the new healthcare environment, with the goal of enhancing the value of delivering comprehensive care.
We are dedicated to generating robust clinical and economic evidence increasingly expected by patients, clinicians, and payors in the current healthcare environment, with the goal of encouraging the adoption of innovative new medical therapies that demonstrate superior outcomes.
2
[ "<tag1>", "We", "are", "dedicated", "to", "generating", "robust", "clinical", "and", "economic", "evidence", "increasingly", "expected", "by", "patients", ",", "clinicians", ",", "and", "payors", "in", "the", "new", "healthcare", "environment", ",", "with", "the...
[ "We", "are", "dedicated", "to", "generating", "robust", "clinical", "and", "economic", "evidence", "increasingly", "expected", "by", "patients", ",", "clinicians", ",", "and", "payors", "in", "the", "new", "healthcare", "environment", ",", "with", "the", "goal",...
[ "We", "are", "dedicated", "to", "generating", "robust", "clinical", "and", "economic", "evidence", "increasingly", "expected", "by", "patients", ",", "clinicians", ",", "and", "payors", "in", "the", "current", "healthcare", "environment", ",", "with", "the", "go...
[]
[ "current", "encouraging", "adoption", "innovative", "medical", "therapies", "demonstrate", "superior", "outcomes" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_16_item7_p2_s0
1099800_15_item7_p1_s4
Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy, and Critical Care.
Transcatheter Heart Valve Therapy ("THV"), Surgical Heart Valve Therapy, and Critical Care.
2
[ "<tag1>", "Transcatheter", "Heart", "Valve", "Therapy", ",", "Surgical", "Heart", "Valve", "Therapy", ",", "and", "Critical", "Care", ".", "<tag2>", "Transcatheter", "Heart", "Valve", "Therapy", "(", "\"", "THV", "\"", ")", ",", "Surgical", "Heart", "Valve", ...
[ "Transcatheter", "Heart", "Valve", "Therapy", ",", "Surgical", "Heart", "Valve", "Therapy", ",", "and", "Critical", "Care", "." ]
[ "Transcatheter", "Heart", "Valve", "Therapy", "(", "\"", "THV", "\"", ")", ",", "Surgical", "Heart", "Valve", "Therapy", ",", "and", "Critical", "Care", "." ]
[]
[ "THV" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, 0, -100, -100, -100, 1, -100, -100, -100, -100, -100, -100, -100, 0, -100, 0, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p19_s0
1099800_15_item7_p26_s0
The $24.9 million increase in net sales of Surgical Heart Valve Therapy products in 2014 was due primarily to:
The decrease in net sales of Surgical Heart Valve Therapy products was due primarily to:
2
[ "<tag1>", "The", "$", "24.9", "million", "increase", "in", "net", "sales", "of", "Surgical", "Heart", "Valve", "Therapy", "products", "in", "2014", "was", "due", "primarily", "to", ":", "<tag2>", "The", "decrease", "in", "net", "sales", "of", "Surgical", "...
[ "The", "$", "24.9", "million", "increase", "in", "net", "sales", "of", "Surgical", "Heart", "Valve", "Therapy", "products", "in", "2014", "was", "due", "primarily", "to", ":" ]
[ "The", "decrease", "in", "net", "sales", "of", "Surgical", "Heart", "Valve", "Therapy", "products", "was", "due", "primarily", "to", ":" ]
[]
[ "decrease" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 1, -100, -100, 0, -100, -100, -100, -100, -100, -100, 0, 0, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p19_s0
1099800_15_item7_p28_s0
The $13.7 million increase in net sales of Surgical Heart Valve Therapy products in 2013 was due primarily to:
The decrease in net sales of Surgical Heart Valve Therapy products was due primarily to:
2
[ "<tag1>", "The", "$", "13.7", "million", "increase", "in", "net", "sales", "of", "Surgical", "Heart", "Valve", "Therapy", "products", "in", "2013", "was", "due", "primarily", "to", ":", "<tag2>", "The", "decrease", "in", "net", "sales", "of", "Surgical", "...
[ "The", "$", "13.7", "million", "increase", "in", "net", "sales", "of", "Surgical", "Heart", "Valve", "Therapy", "products", "in", "2013", "was", "due", "primarily", "to", ":" ]
[ "The", "decrease", "in", "net", "sales", "of", "Surgical", "Heart", "Valve", "Therapy", "products", "was", "due", "primarily", "to", ":" ]
[]
[ "decrease" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 1, -100, -100, 0, -100, -100, -100, 0, -100, -100, 0, -100, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p12_s0
1099800_15_item7_p29_s0
foreign currency exchange rate fluctuations, which decreased net sales by $20.2 million, due primarily to the weakening of the Japanese yen against the United States dollar.
foreign currency exchange rate fluctuations, which decreased net sales by $71.2 million , due primarily to the weakening of the Euro against the United States dollar.
2
[ "<tag1>", "foreign", "currency", "exchange", "rate", "fluctuations", ",", "which", "decreased", "net", "sales", "by", "$", "20.2", "million", ",", "due", "primarily", "to", "the", "weakening", "of", "the", "Japanese", "yen", "against", "the", "United", "States...
[ "foreign", "currency", "exchange", "rate", "fluctuations", ",", "which", "decreased", "net", "sales", "by", "$", "20.2", "million", ",", "due", "primarily", "to", "the", "weakening", "of", "the", "Japanese", "yen", "against", "the", "United", "States", "dollar...
[ "foreign", "currency", "exchange", "rate", "fluctuations", ",", "which", "decreased", "net", "sales", "by", "$", "71.2", "million", ",", "due", "primarily", "to", "the", "weakening", "of", "the", "Euro", "against", "the", "United", "States", "dollar", "." ]
[]
[ "71.2", "Euro" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, 0, 0, -100, -100, 0, -100, -...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p26_s0
1099800_15_item7_p34_s0
The 1.6 percentage point decrease in gross profit as a percentage of net sales in 2014 was driven by:
The increase in gross profit as a percentage of net sales in 2015 was driven by:
2
[ "<tag1>", "The", "1.6", "percentage", "point", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2014", "was", "driven", "by", ":", "<tag2>", "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of"...
[ "The", "1.6", "percentage", "point", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2014", "was", "driven", "by", ":" ]
[ "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2015", "was", "driven", "by", ":" ]
[]
[ "increase" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 1, -100, 0, -100, -100, 0, -100, -100, -100, -100, -100, -100, -100, -100, 0, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p29_s0
1099800_15_item7_p35_s0
a 0.8 percentage point increase due to an improved product mix in the United States, driven by Transcatheter Heart Valve Therapy products.
a 0.8 percentage point increase due to an improved product mix in the United States, driven by THV products.
2
[ "<tag1>", "a", "0.8", "percentage", "point", "increase", "due", "to", "an", "improved", "product", "mix", "in", "the", "United", "States", ",", "driven", "by", "Transcatheter", "Heart", "Valve", "Therapy", "products", ".", "<tag2>", "a", "0.8", "percentage", ...
[ "a", "0.8", "percentage", "point", "increase", "due", "to", "an", "improved", "product", "mix", "in", "the", "United", "States", ",", "driven", "by", "Transcatheter", "Heart", "Valve", "Therapy", "products", "." ]
[ "a", "0.8", "percentage", "point", "increase", "due", "to", "an", "improved", "product", "mix", "in", "the", "United", "States", ",", "driven", "by", "THV", "products", "." ]
[]
[ "THV" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, 0, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -10...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p26_s0
1099800_15_item7_p36_s0
The 0.5 percentage point increase in gross profit as a percentage of net sales in 2013 was driven by:
The increase in gross profit as a percentage of net sales in 2015 was driven by:
2
[ "<tag1>", "The", "0.5", "percentage", "point", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2013", "was", "driven", "by", ":", "<tag2>", "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of"...
[ "The", "0.5", "percentage", "point", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2013", "was", "driven", "by", ":" ]
[ "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2015", "was", "driven", "by", ":" ]
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p28_s0
1099800_15_item7_p36_s0
The 0.5 percentage point increase in gross profit as a percentage of net sales in 2013 was driven by:
The decrease in gross profit as a percentage of net sales in 2014 was driven by:
2
[ "<tag1>", "The", "0.5", "percentage", "point", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2013", "was", "driven", "by", ":", "<tag2>", "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of"...
[ "The", "0.5", "percentage", "point", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2013", "was", "driven", "by", ":" ]
[ "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2014", "was", "driven", "by", ":" ]
[]
[ "decrease" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 1, -100, -100, 0, -100, -100, 0, -100, -100, -100, -100, -100, -100, 0, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p31_s0
1099800_15_item7_p38_s0
The $124.6 million increase in SG A expenses in 2014 was due primarily to (1) higher sales and marketing expenses in the United States, Europe, and Japan, mainly to support the Transcatheter Heart Valve Therapy program, and (2) higher performance-based incentive compensation.
The increase in SG A expenses in 2014 was due primarily to (1) higher sales and marketing expenses in the United States, Europe, and Japan, mainly to support our THV program and (2) higher performance-based incentive compensation.
2
[ "<tag1>", "The", "$", "124.6", "million", "increase", "in", "SG", "A", "expenses", "in", "2014", "was", "due", "primarily", "to", "(", "1", ")", "higher", "sales", "and", "marketing", "expenses", "in", "the", "United", "States", ",", "Europe", ",", "and"...
[ "The", "$", "124.6", "million", "increase", "in", "SG", "A", "expenses", "in", "2014", "was", "due", "primarily", "to", "(", "1", ")", "higher", "sales", "and", "marketing", "expenses", "in", "the", "United", "States", ",", "Europe", ",", "and", "Japan",...
[ "The", "increase", "in", "SG", "A", "expenses", "in", "2014", "was", "due", "primarily", "to", "(", "1", ")", "higher", "sales", "and", "marketing", "expenses", "in", "the", "United", "States", ",", "Europe", ",", "and", "Japan", ",", "mainly", "to", "...
[]
[ "THV" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_16_item7_p33_s0
1099800_15_item7_p40_s0
The increase in research and development expenses in 2014 was due primarily to new aortic and mitral Transcatheter Heart Valve Therapy product development efforts, additional investments in clinical studies in the Surgical Heart Valve Therapy program, and higher performance-based incentive compensation.
The increase in R D expenses in 2014 was due primarily to new THV product development efforts, additional investments in clinical studies in our Surgical Heart Valve Therapy program, and higher performance-based incentive compensation.
2
[ "<tag1>", "The", "increase", "in", "research", "and", "development", "expenses", "in", "2014", "was", "due", "primarily", "to", "new", "aortic", "and", "mitral", "Transcatheter", "Heart", "Valve", "Therapy", "product", "development", "efforts", ",", "additional", ...
[ "The", "increase", "in", "research", "and", "development", "expenses", "in", "2014", "was", "due", "primarily", "to", "new", "aortic", "and", "mitral", "Transcatheter", "Heart", "Valve", "Therapy", "product", "development", "efforts", ",", "additional", "investmen...
[ "The", "increase", "in", "R", "D", "expenses", "in", "2014", "was", "due", "primarily", "to", "new", "THV", "product", "development", "efforts", ",", "additional", "investments", "in", "clinical", "studies", "in", "our", "Surgical", "Heart", "Valve", "Therapy"...
[]
[ "R", "THV" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_16_item7_p33_s1
1099800_15_item7_p40_s1
The decrease in research and development expenses as a percentage of net sales was due primarily to higher net sales.
The decrease in R D expenses as a percentage of net sales was due primarily to higher net sales.
2
[ "<tag1>", "The", "decrease", "in", "research", "and", "development", "expenses", "as", "a", "percentage", "of", "net", "sales", "was", "due", "primarily", "to", "higher", "net", "sales", ".", "<tag2>", "The", "decrease", "in", "R", "D", "expenses", "as", "...
[ "The", "decrease", "in", "research", "and", "development", "expenses", "as", "a", "percentage", "of", "net", "sales", "was", "due", "primarily", "to", "higher", "net", "sales", "." ]
[ "The", "decrease", "in", "R", "D", "expenses", "as", "a", "percentage", "of", "net", "sales", "was", "due", "primarily", "to", "higher", "net", "sales", "." ]
[]
[ "R" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, -100, -100, 1, -100, -100, -100, -100, 0, -100, -100, -100, -100, -100, -100, 0, -100, -100, -100...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p47_s0
1099800_15_item7_p56_s0
We recognize interest and penalties, if any, related to uncertain tax positions in the provision for income taxes.
We recognize interest and penalties, if any, related to unrecognized tax benefits in the provision for income taxes.
2
[ "<tag1>", "We", "recognize", "interest", "and", "penalties", ",", "if", "any", ",", "related", "to", "uncertain", "tax", "positions", "in", "the", "provision", "for", "income", "taxes", ".", "<tag2>", "We", "recognize", "interest", "and", "penalties", ",", "...
[ "We", "recognize", "interest", "and", "penalties", ",", "if", "any", ",", "related", "to", "uncertain", "tax", "positions", "in", "the", "provision", "for", "income", "taxes", "." ]
[ "We", "recognize", "interest", "and", "penalties", ",", "if", "any", ",", "related", "to", "unrecognized", "tax", "benefits", "in", "the", "provision", "for", "income", "taxes", "." ]
[]
[ "unrecognized", "benefits" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, 0, 0, -100, -100, -100, 0, -100, -100, 1, -100, 1, 0, 0, -100, -100, 0, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p48_s2
1099800_15_item7_p58_s0
challenge any assessments, if made, and may exercise our right to appeal.
Furthermore, we may later decide to challenge any assessments, if made, and may exercise our right to appeal.
2
[ "<tag1>", "challenge", "any", "assessments", ",", "if", "made", ",", "and", "may", "exercise", "our", "right", "to", "appeal", ".", "<tag2>", "Furthermore", ",", "we", "may", "later", "decide", "to", "challenge", "any", "assessments", ",", "if", "made", ",...
[ "challenge", "any", "assessments", ",", "if", "made", ",", "and", "may", "exercise", "our", "right", "to", "appeal", "." ]
[ "Furthermore", ",", "we", "may", "later", "decide", "to", "challenge", "any", "assessments", ",", "if", "made", ",", "and", "may", "exercise", "our", "right", "to", "appeal", "." ]
[]
[ "Furthermore", "later", "decide" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 1, 0, -100, -100, 1, 1, -100, 0, 0, -100, 0, -100, -100, -100, 0, 0, 0, 0, -100, -100, -100, 0, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p92_s5
1099800_15_item7_p58_s1
The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new ...
We review these tax uncertainties quarterly and adjust the liability as events occur that affect potential liabilities for additional taxes, such as the progress of tax audits, lapsing of applicable statutes of limitations, negotiations between tax authorities, identification of new issues, and issuance of new legislat...
2
[ "<tag1>", "The", "uncertain", "tax", "positions", "are", "reviewed", "quarterly", "and", "adjusted", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "lapsing", "of", "applicable", "statutes", ...
[ "The", "uncertain", "tax", "positions", "are", "reviewed", "quarterly", "and", "adjusted", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "lapsing", "of", "applicable", "statutes", "of", "l...
[ "We", "review", "these", "tax", "uncertainties", "quarterly", "and", "adjust", "the", "liability", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "the", "progress", "of", "tax", "audits", ...
[]
[ "review", "uncertainties", "adjust", "liability", "progress", "audits" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, ...
1099800_16_item7_p51_s1
1099800_15_item7_p60_s1
The case is currently in suspense pending finalization of an Advance Pricing Agreement ("APA") and Joint Committee of Taxation approval.
However, the audits are currently in suspense pending finalization of an Advance Pricing Agreement ("APA") and Joint Committee of Taxation approval.
2
[ "<tag1>", "The", "case", "is", "currently", "in", "suspense", "pending", "finalization", "of", "an", "Advance", "Pricing", "Agreement", "(", "\"", "APA", "\"", ")", "and", "Joint", "Committee", "of", "Taxation", "approval", ".", "<tag2>", "However", ",", "th...
[ "The", "case", "is", "currently", "in", "suspense", "pending", "finalization", "of", "an", "Advance", "Pricing", "Agreement", "(", "\"", "APA", "\"", ")", "and", "Joint", "Committee", "of", "Taxation", "approval", "." ]
[ "However", ",", "the", "audits", "are", "currently", "in", "suspense", "pending", "finalization", "of", "an", "Advance", "Pricing", "Agreement", "(", "\"", "APA", "\"", ")", "and", "Joint", "Committee", "of", "Taxation", "approval", "." ]
[]
[ "However", "audits" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 1, -100, -100, 1, -100, 0, -100, -100, -100, -100, -100, -100, -100, 0, -100...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p58_s2
1099800_15_item7_p69_s0
time, seek to take advantage of favorable interest rate environments or other market conditions.
However, we periodically consider various financing alternatives and may, from time to time, seek to take advantage of favorable interest rate environments or other market conditions.
2
[ "<tag1>", "time", ",", "seek", "to", "take", "advantage", "of", "favorable", "interest", "rate", "environments", "or", "other", "market", "conditions", ".", "<tag2>", "However", ",", "we", "periodically", "consider", "various", "financing", "alternatives", "and", ...
[ "time", ",", "seek", "to", "take", "advantage", "of", "favorable", "interest", "rate", "environments", "or", "other", "market", "conditions", "." ]
[ "However", ",", "we", "periodically", "consider", "various", "financing", "alternatives", "and", "may", ",", "from", "time", "to", "time", ",", "seek", "to", "take", "advantage", "of", "favorable", "interest", "rate", "environments", "or", "other", "market", "...
[]
[ "However", "periodically", "consider", "various", "financing", "alternatives", "may" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 1, 0, -100, 1, 1, 1, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100, 0, 0, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p60_s0
1099800_15_item7_p71_s2
The majority of cash and cash equivalents and short-term investments held outside the United States relates to undistributed earnings of certain of our foreign subsidiaries, which are considered by us to be indefinitely reinvested.
Cash and cash equivalents and short-term investments held outside the United States have historically been used to fund international operations and acquire businesses and assets outside of the United States, the majority of which relates to undistributed earnings of certain of our foreign subsidiaries, which are consi...
2
[ "<tag1>", "The", "majority", "of", "cash", "and", "cash", "equivalents", "and", "short", "-", "term", "investments", "held", "outside", "the", "United", "States", "relates", "to", "undistributed", "earnings", "of", "certain", "of", "our", "foreign", "subsidiarie...
[ "The", "majority", "of", "cash", "and", "cash", "equivalents", "and", "short", "-", "term", "investments", "held", "outside", "the", "United", "States", "relates", "to", "undistributed", "earnings", "of", "certain", "of", "our", "foreign", "subsidiaries", ",", ...
[ "Cash", "and", "cash", "equivalents", "and", "short", "-", "term", "investments", "held", "outside", "the", "United", "States", "have", "historically", "been", "used", "to", "fund", "international", "operations", "and", "acquire", "businesses", "and", "assets", ...
[]
[ "Cash", "historically", "used", "fund", "international", "operations", "acquire", "businesses", "assets" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_16_item7_p6_s1
1099800_15_item7_p8_s1
Our success is measured both by the development of innovative products and the value we bring to our stakeholders.
Our success is measured both by the development of innovative therapies and the value they bring to our stakeholders.
2
[ "<tag1>", "Our", "success", "is", "measured", "both", "by", "the", "development", "of", "innovative", "products", "and", "the", "value", "we", "bring", "to", "our", "stakeholders", ".", "<tag2>", "Our", "success", "is", "measured", "both", "by", "the", "deve...
[ "Our", "success", "is", "measured", "both", "by", "the", "development", "of", "innovative", "products", "and", "the", "value", "we", "bring", "to", "our", "stakeholders", "." ]
[ "Our", "success", "is", "measured", "both", "by", "the", "development", "of", "innovative", "therapies", "and", "the", "value", "they", "bring", "to", "our", "stakeholders", "." ]
[]
[ "therapies" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, 0, -100, -100, -100, -100, -100, 0, 1, -100, -100, -100, -100, 0, -100, -100, -100, -100...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_16_item7_p6_s4
1099800_15_item7_p8_s4
In a consolidating industry, we believe our focus on innovation and a robust product pipeline will continue to help us compete more effectively, sustain our successes, and build long-term value for our shareholders.
In a consolidating industry, we believe our focus on innovation and a robust product pipeline of meaningful new technologies will help us continue to be a preferred partner, sustain our successes, and build long-term value for our shareholders.
2
[ "<tag1>", "In", "a", "consolidating", "industry", ",", "we", "believe", "our", "focus", "on", "innovation", "and", "a", "robust", "product", "pipeline", "will", "continue", "to", "help", "us", "compete", "more", "effectively", ",", "sustain", "our", "successes...
[ "In", "a", "consolidating", "industry", ",", "we", "believe", "our", "focus", "on", "innovation", "and", "a", "robust", "product", "pipeline", "will", "continue", "to", "help", "us", "compete", "more", "effectively", ",", "sustain", "our", "successes", ",", ...
[ "In", "a", "consolidating", "industry", ",", "we", "believe", "our", "focus", "on", "innovation", "and", "a", "robust", "product", "pipeline", "of", "meaningful", "new", "technologies", "will", "help", "us", "continue", "to", "be", "a", "preferred", "partner",...
[]
[ "meaningful", "new", "technologies", "preferred", "partner" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_16_item7_p87_s0
1099800_15_item7_p95_s0
Indefinite-lived intangible assets, which relate to IPR D acquired in business combinations, are reviewed for impairment annually, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired.
IPR D acquired in business combinations is reviewed for impairment annually, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired.
2
[ "<tag1>", "Indefinite", "-", "lived", "intangible", "assets", ",", "which", "relate", "to", "IPR", "D", "acquired", "in", "business", "combinations", ",", "are", "reviewed", "for", "impairment", "annually", ",", "or", "whenever", "an", "event", "occurs", "or",...
[ "Indefinite", "-", "lived", "intangible", "assets", ",", "which", "relate", "to", "IPR", "D", "acquired", "in", "business", "combinations", ",", "are", "reviewed", "for", "impairment", "annually", ",", "or", "whenever", "an", "event", "occurs", "or", "circumst...
[ "IPR", "D", "acquired", "in", "business", "combinations", "is", "reviewed", "for", "impairment", "annually", ",", "or", "whenever", "an", "event", "occurs", "or", "circumstances", "change", "that", "would", "indicate", "the", "carrying", "amount", "may", "be", ...
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_16_item7_p49_s0
1099800_15_item7_p97_s5
We review these tax uncertainties quarterly and adjust the liability as events occur that affect potential liabilities for additional taxes, such as the progress of tax audits, lapsing of applicable statutes of limitations, negotiations between tax authorities, identification of new issues, and issuance of new legislat...
The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new ...
2
[ "<tag1>", "We", "review", "these", "tax", "uncertainties", "quarterly", "and", "adjust", "the", "liability", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "the", "progress", "of", "tax", ...
[ "We", "review", "these", "tax", "uncertainties", "quarterly", "and", "adjust", "the", "liability", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "the", "progress", "of", "tax", "audits", ...
[ "The", "uncertain", "tax", "positions", "are", "reviewed", "quarterly", "and", "adjusted", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "lapsing", "of", "applicable", "statutes", "of", "l...
[]
[ "uncertain", "positions", "reviewed", "adjusted", "proposed", "assessments" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, ...
1099800_17_item7_p22_s0
1099800_16_item7_p11_s0
The increase in international net sales of THV products was due primarily to:
The increase in net sales of Critical Care products was due primarily to:
2
[ "<tag1>", "The", "increase", "in", "international", "net", "sales", "of", "THV", "products", "was", "due", "primarily", "to", ":", "<tag2>", "The", "increase", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primarily", "to", ":", ...
[ "The", "increase", "in", "international", "net", "sales", "of", "THV", "products", "was", "due", "primarily", "to", ":" ]
[ "The", "increase", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primarily", "to", ":" ]
[]
[ "Critical", "Care" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 0, 0, -100, -100, 0, 1, 1, 0, 0, -100, 0, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p18_s0
1099800_16_item7_p12_s0
foreign currency exchange rate fluctuations, which decreased net sales by $71.2 million , due primarily to the weakening of the Euro against the United States dollar.
foreign currency exchange rate fluctuations, which increased net sales by $2.2 million , due primarily to the strengthening of the Japanese yen against the United States dollar, partially offset by the weakening of various currencies against the United States dollar.
2
[ "<tag1>", "foreign", "currency", "exchange", "rate", "fluctuations", ",", "which", "decreased", "net", "sales", "by", "$", "71.2", "million", ",", "due", "primarily", "to", "the", "weakening", "of", "the", "Euro", "against", "the", "United", "States", "dollar"...
[ "foreign", "currency", "exchange", "rate", "fluctuations", ",", "which", "decreased", "net", "sales", "by", "$", "71.2", "million", ",", "due", "primarily", "to", "the", "weakening", "of", "the", "Euro", "against", "the", "United", "States", "dollar", "." ]
[ "foreign", "currency", "exchange", "rate", "fluctuations", ",", "which", "increased", "net", "sales", "by", "$", "2.2", "million", ",", "due", "primarily", "to", "the", "strengthening", "of", "the", "Japanese", "yen", "against", "the", "United", "States", "dol...
[]
[ "increased", "2.2", "strengthening", "Japanese", "yen", "partially", "offset", "various", "currencies" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 0, -100, 0, 0, -100, 0, 1, 0, -100, 0, 0, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_17_item7_p13_s0
1099800_16_item7_p15_s0
Sales of the Edwards SAPIEN transcatheter heart valve decreased as customers converted to Edwards SAPIEN XT .
lower sales of the Edwards SAPIEN valve as customers converted to Edwards SAPIEN XT.
2
[ "<tag1>", "Sales", "of", "the", "Edwards", "SAPIEN", "transcatheter", "heart", "valve", "decreased", "as", "customers", "converted", "to", "Edwards", "SAPIEN", "XT", ".", "<tag2>", "lower", "sales", "of", "the", "Edwards", "SAPIEN", "valve", "as", "customers", ...
[ "Sales", "of", "the", "Edwards", "SAPIEN", "transcatheter", "heart", "valve", "decreased", "as", "customers", "converted", "to", "Edwards", "SAPIEN", "XT", "." ]
[ "lower", "sales", "of", "the", "Edwards", "SAPIEN", "valve", "as", "customers", "converted", "to", "Edwards", "SAPIEN", "XT", "." ]
[]
[ "lower", "sales" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 1, 1, 0, -100, 0, -100, 0, -100, 0, -100, -100, 0, -100, 0, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p22_s0
1099800_16_item7_p16_s0
The increase in international net sales of THV products was due primarily to:
The increase in net sales of Critical Care products was due primarily to:
2
[ "<tag1>", "The", "increase", "in", "international", "net", "sales", "of", "THV", "products", "was", "due", "primarily", "to", ":", "<tag2>", "The", "increase", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primarily", "to", ":", ...
[ "The", "increase", "in", "international", "net", "sales", "of", "THV", "products", "was", "due", "primarily", "to", ":" ]
[ "The", "increase", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primarily", "to", ":" ]
[]
[ "Critical", "Care" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, 0, 0, -100, 1, 1, 0, 0, -100, 0, 0, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p17_s0
1099800_16_item7_p19_s0
The decrease in net sales of Surgical Heart Valve Therapy products was due primarily to:
The decrease in net sales of SHVT products was due primarily to:
2
[ "<tag1>", "The", "decrease", "in", "net", "sales", "of", "Surgical", "Heart", "Valve", "Therapy", "products", "was", "due", "primarily", "to", ":", "<tag2>", "The", "decrease", "in", "net", "sales", "of", "SHVT", "products", "was", "due", "primarily", "to", ...
[ "The", "decrease", "in", "net", "sales", "of", "Surgical", "Heart", "Valve", "Therapy", "products", "was", "due", "primarily", "to", ":" ]
[ "The", "decrease", "in", "net", "sales", "of", "SHVT", "products", "was", "due", "primarily", "to", ":" ]
[]
[ "SHVT" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, 0, 0, -100, -100, 1, -100, -100, -100, 0, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p19_s0
1099800_16_item7_p19_s0
The decrease in net sales of Surgical Heart Valve Therapy products was due primarily to:
The decrease in net sales of SHVT products was due primarily to:
2
[ "<tag1>", "The", "decrease", "in", "net", "sales", "of", "Surgical", "Heart", "Valve", "Therapy", "products", "was", "due", "primarily", "to", ":", "<tag2>", "The", "decrease", "in", "net", "sales", "of", "SHVT", "products", "was", "due", "primarily", "to", ...
[ "The", "decrease", "in", "net", "sales", "of", "Surgical", "Heart", "Valve", "Therapy", "products", "was", "due", "primarily", "to", ":" ]
[ "The", "decrease", "in", "net", "sales", "of", "SHVT", "products", "was", "due", "primarily", "to", ":" ]
[]
[ "SHVT" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 0, -100, 0, -100, 0, 1, -100, -100, -100, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p22_s0
1099800_16_item7_p21_s0
The increase in net sales of Surgical Heart Valve Therapy products was due primarily to:
The increase in net sales of Critical Care products was due primarily to:
2
[ "<tag1>", "The", "increase", "in", "net", "sales", "of", "Surgical", "Heart", "Valve", "Therapy", "products", "was", "due", "primarily", "to", ":", "<tag2>", "The", "increase", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primar...
[ "The", "increase", "in", "net", "sales", "of", "Surgical", "Heart", "Valve", "Therapy", "products", "was", "due", "primarily", "to", ":" ]
[ "The", "increase", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primarily", "to", ":" ]
[]
[ "Critical", "Care" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, 0, 0, -100, -100, 0, 1, 1, -100, 0, -100, -100, 0, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p17_s0
1099800_16_item7_p23_s0
The decrease in net sales of Critical Care products was due primarily to:
The decrease in net sales of SHVT products was due primarily to:
2
[ "<tag1>", "The", "decrease", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primarily", "to", ":", "<tag2>", "The", "decrease", "in", "net", "sales", "of", "SHVT", "products", "was", "due", "primarily", "to", ":", "<tag3>" ]
[ "The", "decrease", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primarily", "to", ":" ]
[ "The", "decrease", "in", "net", "sales", "of", "SHVT", "products", "was", "due", "primarily", "to", ":" ]
[]
[ "SHVT" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, 0, -100, -100, 1, -100, -100, -100, -100, 0, 0, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p19_s0
1099800_16_item7_p23_s0
The decrease in net sales of Critical Care products was due primarily to:
The decrease in net sales of SHVT products was due primarily to:
2
[ "<tag1>", "The", "decrease", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primarily", "to", ":", "<tag2>", "The", "decrease", "in", "net", "sales", "of", "SHVT", "products", "was", "due", "primarily", "to", ":", "<tag3>" ]
[ "The", "decrease", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primarily", "to", ":" ]
[ "The", "decrease", "in", "net", "sales", "of", "SHVT", "products", "was", "due", "primarily", "to", ":" ]
[]
[ "SHVT" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, -100, 0, -100, -100, -100, 1, -100, -100, -100, 0, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p27_s0
1099800_16_item7_p26_s0
The increase in gross profit as a percentage of net sales in 2015 was driven by:
The decrease in gross profit as a percentage of net sales in 2016 was driven by:
2
[ "<tag1>", "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2015", "was", "driven", "by", ":", "<tag2>", "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "201...
[ "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2015", "was", "driven", "by", ":" ]
[ "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2016", "was", "driven", "by", ":" ]
[]
[ "decrease" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 1, 0, -100, -100, -100, 0, -100, -100, -100, -100, -100, -100, -100, -100, -100, 0, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p27_s0
1099800_16_item7_p28_s0
The decrease in gross profit as a percentage of net sales in 2014 was driven by:
The decrease in gross profit as a percentage of net sales in 2016 was driven by:
2
[ "<tag1>", "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2014", "was", "driven", "by", ":", "<tag2>", "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "201...
[ "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2014", "was", "driven", "by", ":" ]
[ "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2016", "was", "driven", "by", ":" ]
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p29_s0
1099800_16_item7_p28_s0
The decrease in gross profit as a percentage of net sales in 2014 was driven by:
The increase in gross profit as a percentage of net sales in 2015 was driven by:
2
[ "<tag1>", "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2014", "was", "driven", "by", ":", "<tag2>", "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "201...
[ "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2014", "was", "driven", "by", ":" ]
[ "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2015", "was", "driven", "by", ":" ]
[]
[ "increase" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, 1, 0, -100, -100, -100, -100, -100, -100, -100, 0, -100, -100, -100, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p34_s0
1099800_16_item7_p32_s0
The increase in R D expenses in 2015 was due primarily to new THV and Surgical Heart Valve Therapy product development efforts.
The increase in R D expenses in 2015 was due primarily to new THVT and SHVT product development efforts.
2
[ "<tag1>", "The", "increase", "in", "R", "D", "expenses", "in", "2015", "was", "due", "primarily", "to", "new", "THV", "and", "Surgical", "Heart", "Valve", "Therapy", "product", "development", "efforts", ".", "<tag2>", "The", "increase", "in", "R", "D", "ex...
[ "The", "increase", "in", "R", "D", "expenses", "in", "2015", "was", "due", "primarily", "to", "new", "THV", "and", "Surgical", "Heart", "Valve", "Therapy", "product", "development", "efforts", "." ]
[ "The", "increase", "in", "R", "D", "expenses", "in", "2015", "was", "due", "primarily", "to", "new", "THVT", "and", "SHVT", "product", "development", "efforts", "." ]
[]
[ "THVT", "SHVT" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, 0, 0, -100, -100, -100, -100, -100, -100, 0, 0, -100, -100, 1, -100, 1, -100, -100,...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p38_s1
1099800_16_item7_p38_s1
The increase in interest income for 2015 resulted primarily from higher average investment balances and higher average interest rates.
The increase in interest income for 2016 resulted primarily from higher average interest rates.
2
[ "<tag1>", "The", "increase", "in", "interest", "income", "for", "2015", "resulted", "primarily", "from", "higher", "average", "investment", "balances", "and", "higher", "average", "interest", "rates", ".", "<tag2>", "The", "increase", "in", "interest", "income", ...
[ "The", "increase", "in", "interest", "income", "for", "2015", "resulted", "primarily", "from", "higher", "average", "investment", "balances", "and", "higher", "average", "interest", "rates", "." ]
[ "The", "increase", "in", "interest", "income", "for", "2016", "resulted", "primarily", "from", "higher", "average", "interest", "rates", "." ]
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p38_s1
1099800_16_item7_p38_s2
The increase in interest income for 2014 resulted primarily from higher average investment balances.
The increase in interest income for 2016 resulted primarily from higher average interest rates.
2
[ "<tag1>", "The", "increase", "in", "interest", "income", "for", "2014", "resulted", "primarily", "from", "higher", "average", "investment", "balances", ".", "<tag2>", "The", "increase", "in", "interest", "income", "for", "2016", "resulted", "primarily", "from", ...
[ "The", "increase", "in", "interest", "income", "for", "2014", "resulted", "primarily", "from", "higher", "average", "investment", "balances", "." ]
[ "The", "increase", "in", "interest", "income", "for", "2016", "resulted", "primarily", "from", "higher", "average", "interest", "rates", "." ]
[]
[ "rates" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, 0, -100, 0, -100, -100, 0, -100, -100, -100, -100, -100, 1, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p47_s0
1099800_16_item7_p46_s0
A reconciliation of the beginning and ending amount of unrecognized tax benefits, excluding interest, penalties, and foreign exchange, is as follows (in millions):
A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):
2
[ "<tag1>", "A", "reconciliation", "of", "the", "beginning", "and", "ending", "amount", "of", "unrecognized", "tax", "benefits", ",", "excluding", "interest", ",", "penalties", ",", "and", "foreign", "exchange", ",", "is", "as", "follows", "(", "in", "millions",...
[ "A", "reconciliation", "of", "the", "beginning", "and", "ending", "amount", "of", "unrecognized", "tax", "benefits", ",", "excluding", "interest", ",", "penalties", ",", "and", "foreign", "exchange", ",", "is", "as", "follows", "(", "in", "millions", "):" ]
[ "A", "reconciliation", "of", "the", "beginning", "and", "ending", "amount", "of", "uncertain", "tax", "positions", ",", "excluding", "interest", ",", "penalties", ",", "and", "foreign", "exchange", ",", "is", "as", "follows", "(", "in", "millions", "):" ]
[]
[ "uncertain", "positions" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, 0, 0, -100, -100, -100, -100, 1, -...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p48_s0
1099800_16_item7_p47_s0
We recognize interest and penalties, if any, related to unrecognized tax benefits in the provision for income taxes.
We recognize interest and penalties, if any, related to uncertain tax positions in the provision for income taxes.
2
[ "<tag1>", "We", "recognize", "interest", "and", "penalties", ",", "if", "any", ",", "related", "to", "unrecognized", "tax", "benefits", "in", "the", "provision", "for", "income", "taxes", ".", "<tag2>", "We", "recognize", "interest", "and", "penalties", ",", ...
[ "We", "recognize", "interest", "and", "penalties", ",", "if", "any", ",", "related", "to", "unrecognized", "tax", "benefits", "in", "the", "provision", "for", "income", "taxes", "." ]
[ "We", "recognize", "interest", "and", "penalties", ",", "if", "any", ",", "related", "to", "uncertain", "tax", "positions", "in", "the", "provision", "for", "income", "taxes", "." ]
[]
[ "uncertain", "positions" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, 0, -100, -100, 0, 0, -100, 0, 0, 1, -100, 1, -100, -100, -100, -100, -100, -100,...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p100_s5
1099800_16_item7_p49_s0
The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new ...
We review these tax uncertainties quarterly and adjust the liability as events occur that affect potential liabilities for additional taxes, such as the progress of tax audits, lapsing of applicable statutes of limitations, negotiations between tax authorities, identification of new issues, and issuance of new legislat...
2
[ "<tag1>", "The", "uncertain", "tax", "positions", "are", "reviewed", "quarterly", "and", "adjusted", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "lapsing", "of", "applicable", "statutes", ...
[ "The", "uncertain", "tax", "positions", "are", "reviewed", "quarterly", "and", "adjusted", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "lapsing", "of", "applicable", "statutes", "of", "l...
[ "We", "review", "these", "tax", "uncertainties", "quarterly", "and", "adjust", "the", "liability", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "the", "progress", "of", "tax", "audits", ...
[]
[ "review", "uncertainties", "adjust", "liability", "progress", "audits" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, ...
1099800_17_item7_p3_s4
1099800_16_item7_p5_s2
Net income in 2014 benefited from the receipt of $750.0 million ($487.9 million, net of tax) from Medtronic, Inc. ("Medtronic") for an upfront payment due under a litigation settlement agreement.
Net income in 2014 benefited from the receipt of $750.0 million ($487.9 million, net of tax) for an upfront payment due under a litigation settlement agreement.
2
[ "<tag1>", "Net", "income", "in", "2014", "benefited", "from", "the", "receipt", "of", "$", "750.0", "million", "(", "$", "487.9", "million", ",", "net", "of", "tax", ")", "from", "Medtronic", ",", "Inc.", "(", "\"", "Medtronic", "\"", ")", "for", "an",...
[ "Net", "income", "in", "2014", "benefited", "from", "the", "receipt", "of", "$", "750.0", "million", "(", "$", "487.9", "million", ",", "net", "of", "tax", ")", "from", "Medtronic", ",", "Inc.", "(", "\"", "Medtronic", "\"", ")", "for", "an", "upfront"...
[ "Net", "income", "in", "2014", "benefited", "from", "the", "receipt", "of", "$", "750.0", "million", "(", "$", "487.9", "million", ",", "net", "of", "tax", ")", "for", "an", "upfront", "payment", "due", "under", "a", "litigation", "settlement", "agreement"...
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_17_item7_p4_s1
1099800_16_item7_p6_s1
Our success is measured both by the development of innovative therapies and the value they bring to our stakeholders.
Our success is measured both by the development of innovative products and the value we bring to our stakeholders.
2
[ "<tag1>", "Our", "success", "is", "measured", "both", "by", "the", "development", "of", "innovative", "therapies", "and", "the", "value", "they", "bring", "to", "our", "stakeholders", ".", "<tag2>", "Our", "success", "is", "measured", "both", "by", "the", "d...
[ "Our", "success", "is", "measured", "both", "by", "the", "development", "of", "innovative", "therapies", "and", "the", "value", "they", "bring", "to", "our", "stakeholders", "." ]
[ "Our", "success", "is", "measured", "both", "by", "the", "development", "of", "innovative", "products", "and", "the", "value", "we", "bring", "to", "our", "stakeholders", "." ]
[]
[ "products" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, -100, 0, -100, 1, -100, -100, -100, -100, -100, 0, -100, -100, 0...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p4_s4
1099800_16_item7_p6_s5
The following is a summary of important developments during 2015 :
The following is a summary of important developments during 2016 :
2
[ "<tag1>", "The", "following", "is", "a", "summary", "of", "important", "developments", "during", "2015", ":", "<tag2>", "The", "following", "is", "a", "summary", "of", "important", "developments", "during", "2016", ":", "<tag3>" ]
[ "The", "following", "is", "a", "summary", "of", "important", "developments", "during", "2015", ":" ]
[ "The", "following", "is", "a", "summary", "of", "important", "developments", "during", "2016", ":" ]
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_17_item7_p50_s0
1099800_16_item7_p92_s5
We review these tax uncertainties quarterly and adjust the liability as events occur that affect potential liabilities for additional taxes, such as the progress of tax audits, lapsing of applicable statutes of limitations, negotiations between tax authorities, identification of new issues, and issuance of new legislat...
The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new ...
2
[ "<tag1>", "We", "review", "these", "tax", "uncertainties", "quarterly", "and", "adjust", "the", "liability", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "the", "progress", "of", "tax", ...
[ "We", "review", "these", "tax", "uncertainties", "quarterly", "and", "adjust", "the", "liability", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "the", "progress", "of", "tax", "audits", ...
[ "The", "uncertain", "tax", "positions", "are", "reviewed", "quarterly", "and", "adjusted", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "lapsing", "of", "applicable", "statutes", "of", "l...
[]
[ "uncertain", "positions", "reviewed", "adjusted", "proposed", "assessments" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, ...
1099800_18_item7_p54_s0
1099800_17_item7_p100_s5
We review these tax uncertainties quarterly and adjust the liability as events occur that affect potential liabilities for additional taxes, such as the progress of tax audits, lapsing of applicable statutes of limitations, negotiations between tax authorities, identification of new issues, and issuance of new legislat...
The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new ...
2
[ "<tag1>", "We", "review", "these", "tax", "uncertainties", "quarterly", "and", "adjust", "the", "liability", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "the", "progress", "of", "tax", ...
[ "We", "review", "these", "tax", "uncertainties", "quarterly", "and", "adjust", "the", "liability", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "the", "progress", "of", "tax", "audits", ...
[ "The", "uncertain", "tax", "positions", "are", "reviewed", "quarterly", "and", "adjusted", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "lapsing", "of", "applicable", "statutes", "of", "l...
[]
[ "uncertain", "positions", "reviewed", "adjusted", "proposed", "assessments" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, ...
1099800_18_item7_p16_s0
1099800_17_item7_p14_s0
The increase in international net sales of THVT products was due primarily to:
The increase in net sales of SHVT products was due primarily to:
2
[ "<tag1>", "The", "increase", "in", "international", "net", "sales", "of", "THVT", "products", "was", "due", "primarily", "to", ":", "<tag2>", "The", "increase", "in", "net", "sales", "of", "SHVT", "products", "was", "due", "primarily", "to", ":", "<tag3>" ]
[ "The", "increase", "in", "international", "net", "sales", "of", "THVT", "products", "was", "due", "primarily", "to", ":" ]
[ "The", "increase", "in", "net", "sales", "of", "SHVT", "products", "was", "due", "primarily", "to", ":" ]
[]
[ "SHVT" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, 1, 0, -100, 0, 0, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p22_s0
1099800_17_item7_p14_s0
The increase in international net sales of THVT products was due primarily to:
The increase in net sales of Critical Care products was due primarily to:
2
[ "<tag1>", "The", "increase", "in", "international", "net", "sales", "of", "THVT", "products", "was", "due", "primarily", "to", ":", "<tag2>", "The", "increase", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primarily", "to", ":",...
[ "The", "increase", "in", "international", "net", "sales", "of", "THVT", "products", "was", "due", "primarily", "to", ":" ]
[ "The", "increase", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primarily", "to", ":" ]
[]
[ "Critical", "Care" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 0, -100, -100, -100, 0, 1, 1, -100, 0, 0, -100, 0, 0, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p1_s1
1099800_17_item7_p1_s1
Driven by a passion to help patients, we partner with the world's leading clinicians and researchers and aggressively invest in research and development to transform care for structural heart disease and critically ill patients.
Driven by a passion to help patients, we partner with the world's leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease or require hemodynamic monitoring during surgery and in intensive care.
2
[ "<tag1>", "Driven", "by", "a", "passion", "to", "help", "patients", ",", "we", "partner", "with", "the", "world", "'s", "leading", "clinicians", "and", "researchers", "and", "aggressively", "invest", "in", "research", "and", "development", "to", "transform", "...
[ "Driven", "by", "a", "passion", "to", "help", "patients", ",", "we", "partner", "with", "the", "world", "'s", "leading", "clinicians", "and", "researchers", "and", "aggressively", "invest", "in", "research", "and", "development", "to", "transform", "care", "fo...
[ "Driven", "by", "a", "passion", "to", "help", "patients", ",", "we", "partner", "with", "the", "world", "'s", "leading", "clinicians", "and", "researchers", "and", "invest", "in", "research", "and", "development", "to", "transform", "care", "for", "those", "...
[]
[ "impacted", "require", "hemodynamic", "monitoring", "surgery", "intensive" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, 0, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_18_item7_p16_s0
1099800_17_item7_p22_s0
The increase in net sales of Critical Care products was due primarily to:
The increase in net sales of SHVT products was due primarily to:
2
[ "<tag1>", "The", "increase", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primarily", "to", ":", "<tag2>", "The", "increase", "in", "net", "sales", "of", "SHVT", "products", "was", "due", "primarily", "to", ":", "<tag3>" ]
[ "The", "increase", "in", "net", "sales", "of", "Critical", "Care", "products", "was", "due", "primarily", "to", ":" ]
[ "The", "increase", "in", "net", "sales", "of", "SHVT", "products", "was", "due", "primarily", "to", ":" ]
[]
[ "SHVT" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, 0, 1, -100, -100, 0, 0, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p25_s0
1099800_17_item7_p27_s0
The decrease in gross profit as a percentage of net sales in 2016 was driven by:
The increase in gross profit as a percentage of net sales in 2017 compared to 2016 was driven by:
2
[ "<tag1>", "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2016", "was", "driven", "by", ":", "<tag2>", "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "201...
[ "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2016", "was", "driven", "by", ":" ]
[ "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2017", "compared", "to", "2016", "was", "driven", "by", ":" ]
[]
[ "increase", "2017", "compared" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, 1, 0, 0, -100, 0, -100, -100, 0, -100, 0, -100, 1, 1, 0, 0, -100, 0, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p25_s0
1099800_17_item7_p29_s0
The increase in gross profit as a percentage of net sales in 2015 was driven by:
The increase in gross profit as a percentage of net sales in 2017 compared to 2016 was driven by:
2
[ "<tag1>", "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2015", "was", "driven", "by", ":", "<tag2>", "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "201...
[ "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2015", "was", "driven", "by", ":" ]
[ "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2017", "compared", "to", "2016", "was", "driven", "by", ":" ]
[]
[ "2017", "compared", "2016" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, -100, -100, 0, -100, 0, 0, -100, 0, 0, -100, -100, 1, 1, -100, 1, 0, 0, -100, 0, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p27_s0
1099800_17_item7_p29_s0
The increase in gross profit as a percentage of net sales in 2015 was driven by:
The decrease in gross profit as a percentage of net sales in 2016 compared to 2015 was driven by:
2
[ "<tag1>", "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2015", "was", "driven", "by", ":", "<tag2>", "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "201...
[ "The", "increase", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2015", "was", "driven", "by", ":" ]
[ "The", "decrease", "in", "gross", "profit", "as", "a", "percentage", "of", "net", "sales", "in", "2016", "compared", "to", "2015", "was", "driven", "by", ":" ]
[]
[ "decrease", "2016", "compared" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 1, -100, 0, -100, -100, 0, 0, -100, 0, -100, 0, 1, 1, 0, 0, -100, 0, 0, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p29_s1
1099800_17_item7_p31_s2
The decrease in SG A expenses as a percentage of net sales in 2016 was due primarily to higher sales in the United States and Japan.
The decrease in SG A expenses as a percentage of net sales in 2017 was due primarily to leverage from our higher THVT sales in the United States and Japan.
2
[ "<tag1>", "The", "decrease", "in", "SG", "A", "expenses", "as", "a", "percentage", "of", "net", "sales", "in", "2016", "was", "due", "primarily", "to", "higher", "sales", "in", "the", "United", "States", "and", "Japan", ".", "<tag2>", "The", "decrease", ...
[ "The", "decrease", "in", "SG", "A", "expenses", "as", "a", "percentage", "of", "net", "sales", "in", "2016", "was", "due", "primarily", "to", "higher", "sales", "in", "the", "United", "States", "and", "Japan", "." ]
[ "The", "decrease", "in", "SG", "A", "expenses", "as", "a", "percentage", "of", "net", "sales", "in", "2017", "was", "due", "primarily", "to", "leverage", "from", "our", "higher", "THVT", "sales", "in", "the", "United", "States", "and", "Japan", "." ]
[]
[ "leverage", "THVT" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, -100, -100, 0, -100, 0, -100, -100, 0, -100, -100, -100, 0, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p29_s1
1099800_17_item7_p32_s2
The decrease in SG A expenses as a percentage of net sales in 2015 was due primarily to higher sales in the United States, Europe, and Japan.
The decrease in SG A expenses as a percentage of net sales in 2017 was due primarily to leverage from our higher THVT sales in the United States and Japan.
2
[ "<tag1>", "The", "decrease", "in", "SG", "A", "expenses", "as", "a", "percentage", "of", "net", "sales", "in", "2015", "was", "due", "primarily", "to", "higher", "sales", "in", "the", "United", "States", ",", "Europe", ",", "and", "Japan", ".", "<tag2>",...
[ "The", "decrease", "in", "SG", "A", "expenses", "as", "a", "percentage", "of", "net", "sales", "in", "2015", "was", "due", "primarily", "to", "higher", "sales", "in", "the", "United", "States", ",", "Europe", ",", "and", "Japan", "." ]
[ "The", "decrease", "in", "SG", "A", "expenses", "as", "a", "percentage", "of", "net", "sales", "in", "2017", "was", "due", "primarily", "to", "leverage", "from", "our", "higher", "THVT", "sales", "in", "the", "United", "States", "and", "Japan", "." ]
[]
[ "leverage", "THVT" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, 0, 0, -100, 0, -100, -100, -...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_18_item7_p32_s0
1099800_17_item7_p34_s0
The increase in R D expenses in 2015 was due primarily to new THVT and SHVT product development efforts.
The increase in R D expenses in 2016 compared to 2015 was due primarily to mitral and aortic THVT product development efforts.
2
[ "<tag1>", "The", "increase", "in", "R", "D", "expenses", "in", "2015", "was", "due", "primarily", "to", "new", "THVT", "and", "SHVT", "product", "development", "efforts", ".", "<tag2>", "The", "increase", "in", "R", "D", "expenses", "in", "2016", "compared...
[ "The", "increase", "in", "R", "D", "expenses", "in", "2015", "was", "due", "primarily", "to", "new", "THVT", "and", "SHVT", "product", "development", "efforts", "." ]
[ "The", "increase", "in", "R", "D", "expenses", "in", "2016", "compared", "to", "2015", "was", "due", "primarily", "to", "mitral", "and", "aortic", "THVT", "product", "development", "efforts", "." ]
[]
[ "2016", "compared", "mitral", "aortic" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, 0, 0, 0, 1, 1, 0, 0, 0, -100, 0, 0, 1, -100, 1, 0, 0, 0, -100, 0, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p35_s2
1099800_17_item7_p38_s1
The increase in interest income for 2016 resulted primarily from higher average interest rates.
The increase in interest expense for 2016 as compared to 2015 resulted primarily from higher average interest rates.
2
[ "<tag1>", "The", "increase", "in", "interest", "income", "for", "2016", "resulted", "primarily", "from", "higher", "average", "interest", "rates", ".", "<tag2>", "The", "increase", "in", "interest", "expense", "for", "2016", "as", "compared", "to", "2015", "re...
[ "The", "increase", "in", "interest", "income", "for", "2016", "resulted", "primarily", "from", "higher", "average", "interest", "rates", "." ]
[ "The", "increase", "in", "interest", "expense", "for", "2016", "as", "compared", "to", "2015", "resulted", "primarily", "from", "higher", "average", "interest", "rates", "." ]
[]
[ "expense", "compared", "2015" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 0, 0, -100, 1, -100, 0, -100, 1, -100, 1, 0, 0, 0, -100, 0, 0, 0, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p36_s1
1099800_17_item7_p38_s2
The increase in interest income for 2015 resulted primarily from higher average investment balances and higher average interest rates.
The increase in interest income for 2017 and 2016 resulted primarily from higher average interest rates.
2
[ "<tag1>", "The", "increase", "in", "interest", "income", "for", "2015", "resulted", "primarily", "from", "higher", "average", "investment", "balances", "and", "higher", "average", "interest", "rates", ".", "<tag2>", "The", "increase", "in", "interest", "income", ...
[ "The", "increase", "in", "interest", "income", "for", "2015", "resulted", "primarily", "from", "higher", "average", "investment", "balances", "and", "higher", "average", "interest", "rates", "." ]
[ "The", "increase", "in", "interest", "income", "for", "2017", "and", "2016", "resulted", "primarily", "from", "higher", "average", "interest", "rates", "." ]
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p4_s4
1099800_17_item7_p4_s4
The following is a summary of important developments during 2016 :
The following is a summary of important developments during 2017 :
2
[ "<tag1>", "The", "following", "is", "a", "summary", "of", "important", "developments", "during", "2016", ":", "<tag2>", "The", "following", "is", "a", "summary", "of", "important", "developments", "during", "2017", ":", "<tag3>" ]
[ "The", "following", "is", "a", "summary", "of", "important", "developments", "during", "2016", ":" ]
[ "The", "following", "is", "a", "summary", "of", "important", "developments", "during", "2017", ":" ]
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p108_s5
1099800_17_item7_p50_s0
The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new ...
We review these tax uncertainties quarterly and adjust the liability as events occur that affect potential liabilities for additional taxes, such as the progress of tax audits, lapsing of applicable statutes of limitations, negotiations between tax authorities, identification of new issues, and issuance of new legislat...
2
[ "<tag1>", "The", "uncertain", "tax", "positions", "are", "reviewed", "quarterly", "and", "adjusted", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "lapsing", "of", "applicable", "statutes", ...
[ "The", "uncertain", "tax", "positions", "are", "reviewed", "quarterly", "and", "adjusted", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "lapsing", "of", "applicable", "statutes", "of", "l...
[ "We", "review", "these", "tax", "uncertainties", "quarterly", "and", "adjust", "the", "liability", "as", "events", "occur", "that", "affect", "potential", "liabilities", "for", "additional", "taxes", ",", "such", "as", "the", "progress", "of", "tax", "audits", ...
[]
[ "review", "uncertainties", "adjust", "liability", "progress", "audits" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, ...
1099800_18_item7_p56_s0
1099800_17_item7_p52_s0
The Internal Revenue Service ("IRS") has substantially completed its fieldwork for the 2009 through 2012 tax years.
The IRS has substantially completed its fieldwork for the 2009 through 2012 tax years.
2
[ "<tag1>", "The", "Internal", "Revenue", "Service", "(", "\"", "IRS", "\"", ")", "has", "substantially", "completed", "its", "fieldwork", "for", "the", "2009", "through", "2012", "tax", "years", ".", "<tag2>", "The", "IRS", "has", "substantially", "completed", ...
[ "The", "Internal", "Revenue", "Service", "(", "\"", "IRS", "\"", ")", "has", "substantially", "completed", "its", "fieldwork", "for", "the", "2009", "through", "2012", "tax", "years", "." ]
[ "The", "IRS", "has", "substantially", "completed", "its", "fieldwork", "for", "the", "2009", "through", "2012", "tax", "years", "." ]
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p90_s0
1099800_17_item7_p54_s0
We have been pursuing an APA between the Switzerland and United States governments for the years 2009 through 2013 covering transfer pricing matters with the possibility of a roll-forward of the results to subsequent years.
We had been pursuing an APA between the Switzerland and United States governments for the years 2009 through 2013, with the possibility of a roll-forward of the results to subsequent years.
2
[ "<tag1>", "We", "have", "been", "pursuing", "an", "APA", "between", "the", "Switzerland", "and", "United", "States", "governments", "for", "the", "years", "2009", "through", "2013", "covering", "transfer", "pricing", "matters", "with", "the", "possibility", "of"...
[ "We", "have", "been", "pursuing", "an", "APA", "between", "the", "Switzerland", "and", "United", "States", "governments", "for", "the", "years", "2009", "through", "2013", "covering", "transfer", "pricing", "matters", "with", "the", "possibility", "of", "a", "...
[ "We", "had", "been", "pursuing", "an", "APA", "between", "the", "Switzerland", "and", "United", "States", "governments", "for", "the", "years", "2009", "through", "2013", ",", "with", "the", "possibility", "of", "a", "roll", "-", "forward", "of", "the", "r...
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_18_item7_p90_s3
1099800_17_item7_p54_s2
These transfer pricing matters are significant to our consolidated financial statements as the disputed amounts are material, and the final outcome is uncertain.
These transfer pricing matters are significant to our consolidated financial statements, and the final outcome of the negotiations is uncertain.
2
[ "<tag1>", "These", "transfer", "pricing", "matters", "are", "significant", "to", "our", "consolidated", "financial", "statements", "as", "the", "disputed", "amounts", "are", "material", ",", "and", "the", "final", "outcome", "is", "uncertain", ".", "<tag2>", "Th...
[ "These", "transfer", "pricing", "matters", "are", "significant", "to", "our", "consolidated", "financial", "statements", "as", "the", "disputed", "amounts", "are", "material", ",", "and", "the", "final", "outcome", "is", "uncertain", "." ]
[ "These", "transfer", "pricing", "matters", "are", "significant", "to", "our", "consolidated", "financial", "statements", ",", "and", "the", "final", "outcome", "of", "the", "negotiations", "is", "uncertain", "." ]
[]
[ "negotiations" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, 0, -100, -100, -100, -100, 0, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p60_s2
1099800_17_item7_p57_s2
However, if the APA and/or the appeals process related to the pre-filing agreement is finalized in the next 12 months, it is reasonably possible that these events could result in a significant change in our uncertain tax positions within the next 12 months.
However, if the appeals process related to the pre-filing agreement or transfer pricing matters is finalized in the next 12 months, it is reasonably possible that these events could result in a significant change in our uncertain tax positions within the next 12 months.
2
[ "<tag1>", "However", ",", "if", "the", "APA", "and/or", "the", "appeals", "process", "related", "to", "the", "pre", "-", "filing", "agreement", "is", "finalized", "in", "the", "next", "12", "months", ",", "it", "is", "reasonably", "possible", "that", "thes...
[ "However", ",", "if", "the", "APA", "and/or", "the", "appeals", "process", "related", "to", "the", "pre", "-", "filing", "agreement", "is", "finalized", "in", "the", "next", "12", "months", ",", "it", "is", "reasonably", "possible", "that", "these", "event...
[ "However", ",", "if", "the", "appeals", "process", "related", "to", "the", "pre", "-", "filing", "agreement", "or", "transfer", "pricing", "matters", "is", "finalized", "in", "the", "next", "12", "months", ",", "it", "is", "reasonably", "possible", "that", ...
[]
[ "transfer", "pricing", "matters" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_18_item7_p62_s0
1099800_17_item7_p60_s0
Our DR branch receives tax incentives, including an exemption from paying DR income taxes, under a Free Trade Zone law.
Our Dominican Republic branch receives tax incentives, including an exemption from paying Dominican Republic income taxes, under a Free Trade Zone law.
2
[ "<tag1>", "Our", "DR", "branch", "receives", "tax", "incentives", ",", "including", "an", "exemption", "from", "paying", "DR", "income", "taxes", ",", "under", "a", "Free", "Trade", "Zone", "law", ".", "<tag2>", "Our", "Dominican", "Republic", "branch", "rec...
[ "Our", "DR", "branch", "receives", "tax", "incentives", ",", "including", "an", "exemption", "from", "paying", "DR", "income", "taxes", ",", "under", "a", "Free", "Trade", "Zone", "law", "." ]
[ "Our", "Dominican", "Republic", "branch", "receives", "tax", "incentives", ",", "including", "an", "exemption", "from", "paying", "Dominican", "Republic", "income", "taxes", ",", "under", "a", "Free", "Trade", "Zone", "law", "." ]
[]
[ "Dominican", "Republic", "Dominican", "Republic" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 1, 1, 0, 0, 0, -100, -100, 0, 0, 0, -100, 0, 1, 1, 0, -100, 0, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p62_s1
1099800_17_item7_p60_s1
Effective November 9, 2012, DR enacted a law which, among other tax provisions, would apply a 10% withholding tax on dividends or branch remittances from a Free Trade Zone company to its shareholder(s).
Effective November 9, 2012, the Dominican Republic enacted a law which, among other tax provisions, would apply a 10% withholding tax on dividends or branch remittances from a Free Trade Zone company to its shareholder(s).
2
[ "<tag1>", "Effective", "November", "9", ",", "2012", ",", "DR", "enacted", "a", "law", "which", ",", "among", "other", "tax", "provisions", ",", "would", "apply", "a", "10", "%", "withholding", "tax", "on", "dividends", "or", "branch", "remittances", "from...
[ "Effective", "November", "9", ",", "2012", ",", "DR", "enacted", "a", "law", "which", ",", "among", "other", "tax", "provisions", ",", "would", "apply", "a", "10", "%", "withholding", "tax", "on", "dividends", "or", "branch", "remittances", "from", "a", ...
[ "Effective", "November", "9", ",", "2012", ",", "the", "Dominican", "Republic", "enacted", "a", "law", "which", ",", "among", "other", "tax", "provisions", ",", "would", "apply", "a", "10", "%", "withholding", "tax", "on", "dividends", "or", "branch", "rem...
[]
[ "Dominican", "Republic" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_18_item7_p62_s2
1099800_17_item7_p60_s2
The DR withholding tax provision was, however, contingent upon certain future events.
The Dominican Republic withholding tax provision was, however, contingent upon certain future events.
2
[ "<tag1>", "The", "DR", "withholding", "tax", "provision", "was", ",", "however", ",", "contingent", "upon", "certain", "future", "events", ".", "<tag2>", "The", "Dominican", "Republic", "withholding", "tax", "provision", "was", ",", "however", ",", "contingent",...
[ "The", "DR", "withholding", "tax", "provision", "was", ",", "however", ",", "contingent", "upon", "certain", "future", "events", "." ]
[ "The", "Dominican", "Republic", "withholding", "tax", "provision", "was", ",", "however", ",", "contingent", "upon", "certain", "future", "events", "." ]
[]
[ "Dominican", "Republic" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 1, 1, -100, 0, -100, -100, 0, -100, 0, -100, 0, -100, 0, -100, 0, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p62_s3
1099800_17_item7_p60_s3
On October 5, 2016, the DR Ministry of Finance published a notification confirming that the 10% withholding tax on branch remittances would be due and payable by DR Free Trade Zone companies for dividends and remittances paid on or after October 5, 2016.
On October 5, 2016, the Dominican Republic Ministry of Finance published a notification confirming that the 10% withholding tax on branch remittances would be due and payable by Dominican Republic Free Trade Zone companies for dividends and remittances paid on or after October 5, 2016.
2
[ "<tag1>", "On", "October", "5", ",", "2016", ",", "the", "DR", "Ministry", "of", "Finance", "published", "a", "notification", "confirming", "that", "the", "10", "%", "withholding", "tax", "on", "branch", "remittances", "would", "be", "due", "and", "payable",...
[ "On", "October", "5", ",", "2016", ",", "the", "DR", "Ministry", "of", "Finance", "published", "a", "notification", "confirming", "that", "the", "10", "%", "withholding", "tax", "on", "branch", "remittances", "would", "be", "due", "and", "payable", "by", "...
[ "On", "October", "5", ",", "2016", ",", "the", "Dominican", "Republic", "Ministry", "of", "Finance", "published", "a", "notification", "confirming", "that", "the", "10", "%", "withholding", "tax", "on", "branch", "remittances", "would", "be", "due", "and", "...
[]
[ "Dominican", "Republic", "Dominican", "Republic" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_18_item7_p90_s0
1099800_17_item7_p83_s0
We have been pursuing an APA between the Switzerland and United States governments for the years 2009 through 2013 covering transfer pricing matters with the possibility of a roll-forward of the results to subsequent years.
We had been pursuing an APA between the Switzerland and United States governments for the years 2009 through 2013, with the possibility of a roll-forward of the results to subsequent years.
2
[ "<tag1>", "We", "have", "been", "pursuing", "an", "APA", "between", "the", "Switzerland", "and", "United", "States", "governments", "for", "the", "years", "2009", "through", "2013", "covering", "transfer", "pricing", "matters", "with", "the", "possibility", "of"...
[ "We", "have", "been", "pursuing", "an", "APA", "between", "the", "Switzerland", "and", "United", "States", "governments", "for", "the", "years", "2009", "through", "2013", "covering", "transfer", "pricing", "matters", "with", "the", "possibility", "of", "a", "...
[ "We", "had", "been", "pursuing", "an", "APA", "between", "the", "Switzerland", "and", "United", "States", "governments", "for", "the", "years", "2009", "through", "2013", ",", "with", "the", "possibility", "of", "a", "roll", "-", "forward", "of", "the", "r...
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1099800_18_item7_p58_s3
1099800_17_item7_p83_s1
These transfer pricing matters are significant to our consolidated financial statements, and the final outcome of the negotiations is uncertain.
These transfer pricing matters are significant to our consolidated financial statements as the disputed amounts are material, and the final outcome is uncertain.
2
[ "<tag1>", "These", "transfer", "pricing", "matters", "are", "significant", "to", "our", "consolidated", "financial", "statements", ",", "and", "the", "final", "outcome", "of", "the", "negotiations", "is", "uncertain", ".", "<tag2>", "These", "transfer", "pricing",...
[ "These", "transfer", "pricing", "matters", "are", "significant", "to", "our", "consolidated", "financial", "statements", ",", "and", "the", "final", "outcome", "of", "the", "negotiations", "is", "uncertain", "." ]
[ "These", "transfer", "pricing", "matters", "are", "significant", "to", "our", "consolidated", "financial", "statements", "as", "the", "disputed", "amounts", "are", "material", ",", "and", "the", "final", "outcome", "is", "uncertain", "." ]
[]
[ "disputed", "amounts", "material" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, 0, -100, 0, -100, 0, -100, 0, 0, 1, 1, 0, 1, 0, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1099800_18_item7_p102_s0
1099800_17_item7_p95_s1
Additionally, management reviews the carrying amounts of other intangible and long-lived assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable.
carrying amounts of other intangible and long-lived assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable.
2
[ "<tag1>", "Additionally", ",", "management", "reviews", "the", "carrying", "amounts", "of", "other", "intangible", "and", "long", "-", "lived", "assets", "whenever", "events", "or", "circumstances", "indicate", "that", "the", "carrying", "amounts", "of", "an", "...
[ "Additionally", ",", "management", "reviews", "the", "carrying", "amounts", "of", "other", "intangible", "and", "long", "-", "lived", "assets", "whenever", "events", "or", "circumstances", "indicate", "that", "the", "carrying", "amounts", "of", "an", "asset", "m...
[ "carrying", "amounts", "of", "other", "intangible", "and", "long", "-", "lived", "assets", "whenever", "events", "or", "circumstances", "indicate", "that", "the", "carrying", "amounts", "of", "an", "asset", "may", "not", "be", "recoverable", "." ]
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1108967_12_item7_p39_s1
1108967_11_item7_p37_s1
A former company officer received 111,111 shares in this transaction.
A former company officer received 3,704 shares in this transaction.
2
[ "<tag1>", "A", "former", "company", "officer", "received", "111,111", "shares", "in", "this", "transaction", ".", "<tag2>", "A", "former", "company", "officer", "received", "3,704", "shares", "in", "this", "transaction", ".", "<tag3>" ]
[ "A", "former", "company", "officer", "received", "111,111", "shares", "in", "this", "transaction", "." ]
[ "A", "former", "company", "officer", "received", "3,704", "shares", "in", "this", "transaction", "." ]
[]
[ "3,704" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, -100, -100, -100, -100, 1, -100, 0, 0, -100, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1108967_12_item7_p46_s1
1108967_11_item7_p45_s1
The agreement specifically retained the total maximum convertible shares at 70,000,000 as stated in the original Note.
The agreement specifically retained the total maximum convertible shares at 2,333,333 as stated in the original Note.
2
[ "<tag1>", "The", "agreement", "specifically", "retained", "the", "total", "maximum", "convertible", "shares", "at", "70,000,000", "as", "stated", "in", "the", "original", "Note", ".", "<tag2>", "The", "agreement", "specifically", "retained", "the", "total", "maxim...
[ "The", "agreement", "specifically", "retained", "the", "total", "maximum", "convertible", "shares", "at", "70,000,000", "as", "stated", "in", "the", "original", "Note", "." ]
[ "The", "agreement", "specifically", "retained", "the", "total", "maximum", "convertible", "shares", "at", "2,333,333", "as", "stated", "in", "the", "original", "Note", "." ]
[]
[ "2,333,333" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, 0, -100, -100, -100, -100, -100, 1, -100, 0, -100, -100, -100, 0, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1108967_12_item7_p67_s2
1108967_11_item7_p69_s0
Other income for the year ended December 31, 2010, consisted of $95,771 from a cancelled insurance policy at Comex Electronics, $31,496 for foreign exchange gain, $24,630 for interest income, $20,090 of rental income, and $14,219 in other income.
Other income for the year ended December 31, 2010, consisted of $31,496 for foreign exchange gain, $24,582 for interest income, $20,090 of rental income, and $11,010 in other income.
2
[ "<tag1>", "Other", "income", "for", "the", "year", "ended", "December", "31", ",", "2010", ",", "consisted", "of", "$", "95,771", "from", "a", "cancelled", "insurance", "policy", "at", "Comex", "Electronics", ",", "$", "31,496", "for", "foreign", "exchange",...
[ "Other", "income", "for", "the", "year", "ended", "December", "31", ",", "2010", ",", "consisted", "of", "$", "95,771", "from", "a", "cancelled", "insurance", "policy", "at", "Comex", "Electronics", ",", "$", "31,496", "for", "foreign", "exchange", "gain", ...
[ "Other", "income", "for", "the", "year", "ended", "December", "31", ",", "2010", ",", "consisted", "of", "$", "31,496", "for", "foreign", "exchange", "gain", ",", "$", "24,582", "for", "interest", "income", ",", "$", "20,090", "of", "rental", "income", "...
[]
[ "24,582", "11,010" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1108967_12_item7_p76_s0
1108967_11_item7_p75_s0
The Company had a net loss of $7,460,516 for the year ended December 31, 2010 as compared to a net loss of $16,043,547 for the prior year ended 2009.
The Company had a net profit of $19,109 for the year ended December 31, 2011 as compared to a net loss of $7,460,516 for the year ended December 31, 2010.
2
[ "<tag1>", "The", "Company", "had", "a", "net", "loss", "of", "$", "7,460,516", "for", "the", "year", "ended", "December", "31", ",", "2010", "as", "compared", "to", "a", "net", "loss", "of", "$", "16,043,547", "for", "the", "prior", "year", "ended", "2...
[ "The", "Company", "had", "a", "net", "loss", "of", "$", "7,460,516", "for", "the", "year", "ended", "December", "31", ",", "2010", "as", "compared", "to", "a", "net", "loss", "of", "$", "16,043,547", "for", "the", "prior", "year", "ended", "2009", "." ...
[ "The", "Company", "had", "a", "net", "profit", "of", "$", "19,109", "for", "the", "year", "ended", "December", "31", ",", "2011", "as", "compared", "to", "a", "net", "loss", "of", "$", "7,460,516", "for", "the", "year", "ended", "December", "31", ",", ...
[]
[ "profit", "19,109" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1108967_13_item7_p21_s3
1108967_12_item7_p22_s0
During 2011, CUI Global recorded one significant non-cash entry - $334,747 of non-cash interest expense, including amortization of debt offering costs.
During 2011, the Company recorded one significant non-cash entry - $334,747 of non-cash interest expense, including amortization of debt offering costs.
2
[ "<tag1>", "During", "2011", ",", "CUI", "Global", "recorded", "one", "significant", "non", "-", "cash", "entry", "-", "$", "334,747", "of", "non", "-", "cash", "interest", "expense", ",", "including", "amortization", "of", "debt", "offering", "costs", ".", ...
[ "During", "2011", ",", "CUI", "Global", "recorded", "one", "significant", "non", "-", "cash", "entry", "-", "$", "334,747", "of", "non", "-", "cash", "interest", "expense", ",", "including", "amortization", "of", "debt", "offering", "costs", "." ]
[ "During", "2011", ",", "the", "Company", "recorded", "one", "significant", "non", "-", "cash", "entry", "-", "$", "334,747", "of", "non", "-", "cash", "interest", "expense", ",", "including", "amortization", "of", "debt", "offering", "costs", "." ]
[]
[ "Company" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, -100, -100, -100, 1, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1108967_13_item7_p33_s0
1108967_12_item7_p31_s2
Included in these transactions were the following items, discussed in greater detail at Note 9.
Included in these equity financing transactions were the following items, discussed in greater detail at Note 8 STOCKHOLDERS EQUITY:
2
[ "<tag1>", "Included", "in", "these", "transactions", "were", "the", "following", "items", ",", "discussed", "in", "greater", "detail", "at", "Note", "9", ".", "<tag2>", "Included", "in", "these", "equity", "financing", "transactions", "were", "the", "following",...
[ "Included", "in", "these", "transactions", "were", "the", "following", "items", ",", "discussed", "in", "greater", "detail", "at", "Note", "9", "." ]
[ "Included", "in", "these", "equity", "financing", "transactions", "were", "the", "following", "items", ",", "discussed", "in", "greater", "detail", "at", "Note", "8", "STOCKHOLDERS", "EQUITY", ":" ]
[]
[ "equity", "financing", "8", "STOCKHOLDERS", "EQUITY" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1108967_13_item7_p48_s0
1108967_12_item7_p50_s0
During 2011, the Company continued to improve its financial strength with the divestment of Comex Electronics and the continued reductions in debt coupled with the continued growth of revenues.
During 2012, the Company continued to improve its financial strength with the equity raise in early 2012, the significant reductions in debt coupled with the continued growth of revenues.
2
[ "<tag1>", "During", "2011", ",", "the", "Company", "continued", "to", "improve", "its", "financial", "strength", "with", "the", "divestment", "of", "Comex", "Electronics", "and", "the", "continued", "reductions", "in", "debt", "coupled", "with", "the", "continue...
[ "During", "2011", ",", "the", "Company", "continued", "to", "improve", "its", "financial", "strength", "with", "the", "divestment", "of", "Comex", "Electronics", "and", "the", "continued", "reductions", "in", "debt", "coupled", "with", "the", "continued", "growt...
[ "During", "2012", ",", "the", "Company", "continued", "to", "improve", "its", "financial", "strength", "with", "the", "equity", "raise", "in", "early", "2012", ",", "the", "significant", "reductions", "in", "debt", "coupled", "with", "the", "continued", "growt...
[]
[ "equity", "raise", "early", "2012", "significant" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 0, 0, -100, 0, -100, -100, 0, 0, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1108967_13_item7_p48_s1
1108967_12_item7_p51_s0
As a result of the improvements in 2011 and the activities completed in 2011, management believes the Company has sufficient resources and that it is generating sufficient revenues to fund operations.
As a result of the financing activities completed in 2012, management believes the Company has sufficient resources and is generating sufficient revenues to fund operations.
2
[ "<tag1>", "As", "a", "result", "of", "the", "improvements", "in", "2011", "and", "the", "activities", "completed", "in", "2011", ",", "management", "believes", "the", "Company", "has", "sufficient", "resources", "and", "that", "it", "is", "generating", "suffic...
[ "As", "a", "result", "of", "the", "improvements", "in", "2011", "and", "the", "activities", "completed", "in", "2011", ",", "management", "believes", "the", "Company", "has", "sufficient", "resources", "and", "that", "it", "is", "generating", "sufficient", "re...
[ "As", "a", "result", "of", "the", "financing", "activities", "completed", "in", "2012", ",", "management", "believes", "the", "Company", "has", "sufficient", "resources", "and", "is", "generating", "sufficient", "revenues", "to", "fund", "operations", "." ]
[]
[ "financing" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 0, -100, -100, -100, 1, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1108967_13_item7_p48_s2
1108967_12_item7_p51_s1
As of December 31, 2011 the Company had an accumulated deficit of $73,645,501.
As of December 31, 2012 the Company had an accumulated deficit of $76,171,822.
2
[ "<tag1>", "As", "of", "December", "31", ",", "2011", "the", "Company", "had", "an", "accumulated", "deficit", "of", "$", "73,645,501", ".", "<tag2>", "As", "of", "December", "31", ",", "2012", "the", "Company", "had", "an", "accumulated", "deficit", "of", ...
[ "As", "of", "December", "31", ",", "2011", "the", "Company", "had", "an", "accumulated", "deficit", "of", "$", "73,645,501", "." ]
[ "As", "of", "December", "31", ",", "2012", "the", "Company", "had", "an", "accumulated", "deficit", "of", "$", "76,171,822", "." ]
[]
[ "76,171,822" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, 0, -100, -100, -100, -100, -100, -100, 0, -100, -100, -100, -100, -100, 1, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1108967_13_item7_p51_s1
1108967_12_item7_p54_s1
If revenues and the funds raised in early 2012 through the equity raise are not sufficient to cover all operating and other expenses, additional funding may be required.
If revenues and cash on hand are not sufficient to cover all operating and other expenses, additional funding may be required.
2
[ "<tag1>", "If", "revenues", "and", "the", "funds", "raised", "in", "early", "2012", "through", "the", "equity", "raise", "are", "not", "sufficient", "to", "cover", "all", "operating", "and", "other", "expenses", ",", "additional", "funding", "may", "be", "re...
[ "If", "revenues", "and", "the", "funds", "raised", "in", "early", "2012", "through", "the", "equity", "raise", "are", "not", "sufficient", "to", "cover", "all", "operating", "and", "other", "expenses", ",", "additional", "funding", "may", "be", "required", "...
[ "If", "revenues", "and", "cash", "on", "hand", "are", "not", "sufficient", "to", "cover", "all", "operating", "and", "other", "expenses", ",", "additional", "funding", "may", "be", "required", "." ]
[]
[ "cash", "hand" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 0, -100, 1, 0, 1, -100, -100, -100, -100...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1108967_13_item7_p59_s1
1108967_12_item7_p60_s1
The significant increase during 2011 compared to the prior year is primarily the result of the overall growth in sales and increases in costs associated with manufacturing our products.
The significant increase during 2012 compared to the prior year is primarily the result of the overall growth in sales.
2
[ "<tag1>", "The", "significant", "increase", "during", "2011", "compared", "to", "the", "prior", "year", "is", "primarily", "the", "result", "of", "the", "overall", "growth", "in", "sales", "and", "increases", "in", "costs", "associated", "with", "manufacturing",...
[ "The", "significant", "increase", "during", "2011", "compared", "to", "the", "prior", "year", "is", "primarily", "the", "result", "of", "the", "overall", "growth", "in", "sales", "and", "increases", "in", "costs", "associated", "with", "manufacturing", "our", ...
[ "The", "significant", "increase", "during", "2012", "compared", "to", "the", "prior", "year", "is", "primarily", "the", "result", "of", "the", "overall", "growth", "in", "sales", "." ]
[]
[]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1108967_13_item7_p63_s3
1108967_12_item7_p64_s3
The Company expects that research and development expenses will increase during 2012 as the Company continues to expand its product offering and technologies due to market acceptance and customer integration.
The Company expects that 2013 research and development expenses will be consistent with 2012 as the Company continues to expand its product offering and technologies due to market acceptance and customer integration.
2
[ "<tag1>", "The", "Company", "expects", "that", "research", "and", "development", "expenses", "will", "increase", "during", "2012", "as", "the", "Company", "continues", "to", "expand", "its", "product", "offering", "and", "technologies", "due", "to", "market", "a...
[ "The", "Company", "expects", "that", "research", "and", "development", "expenses", "will", "increase", "during", "2012", "as", "the", "Company", "continues", "to", "expand", "its", "product", "offering", "and", "technologies", "due", "to", "market", "acceptance", ...
[ "The", "Company", "expects", "that", "2013", "research", "and", "development", "expenses", "will", "be", "consistent", "with", "2012", "as", "the", "Company", "continues", "to", "expand", "its", "product", "offering", "and", "technologies", "due", "to", "market"...
[]
[ "consistent" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1108967_16_item7_p17_s0
1108967_15_item7_p19_s0
The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable.
The Company tests for goodwill impairment in the second quarter of each year and whenever events or changes in circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable.
2
[ "<tag1>", "The", "Company", "reviews", "its", "long", "-", "lived", "assets", "for", "impairment", "whenever", "events", "or", "changes", "in", "circumstances", "indicate", "that", "the", "carrying", "amount", "of", "the", "asset", "exceeds", "its", "fair", "v...
[ "The", "Company", "reviews", "its", "long", "-", "lived", "assets", "for", "impairment", "whenever", "events", "or", "changes", "in", "circumstances", "indicate", "that", "the", "carrying", "amount", "of", "the", "asset", "exceeds", "its", "fair", "value", "an...
[ "The", "Company", "tests", "for", "goodwill", "impairment", "in", "the", "second", "quarter", "of", "each", "year", "and", "whenever", "events", "or", "changes", "in", "circumstances", "indicate", "that", "the", "carrying", "amount", "of", "the", "asset", "exc...
[]
[ "tests", "goodwill", "second", "quarter", "year" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, 0, 0, 1, 0, 1, 0, -1...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1108967_16_item7_p19_s5
1108967_15_item7_p21_s4
With regards to the January 2014 options grant, the Company determined expected volatility through the use of the volatility for the most recent twelve month period historical share prices for CUI Global best reflected the expected volatility for determining the fair value of our stock options due to the significant ch...
We determined that the most recent 12-month period of stock price fluctuations best reflected the expected volatility for determining the fair value of our stock options due to the significant changes to the Company, including the 2013 equity raise, acquisition of Orbital, increased institutional ownership and other su...
2
[ "<tag1>", "With", "regards", "to", "the", "January", "2014", "options", "grant", ",", "the", "Company", "determined", "expected", "volatility", "through", "the", "use", "of", "the", "volatility", "for", "the", "most", "recent", "twelve", "month", "period", "hi...
[ "With", "regards", "to", "the", "January", "2014", "options", "grant", ",", "the", "Company", "determined", "expected", "volatility", "through", "the", "use", "of", "the", "volatility", "for", "the", "most", "recent", "twelve", "month", "period", "historical", ...
[ "We", "determined", "that", "the", "most", "recent", "12", "-", "month", "period", "of", "stock", "price", "fluctuations", "best", "reflected", "the", "expected", "volatility", "for", "determining", "the", "fair", "value", "of", "our", "stock", "options", "due...
[]
[ "12", "price", "fluctuations" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...
1108967_16_item7_p27_s0
1108967_15_item7_p24_s0
Product revenue is recognized in the period when persuasive evidence of an arrangement with a customer exists, the products are shipped and title has transferred to the customer, the price is fixed or determinable, and collection is reasonably assured.
For product sales in the Energy segment, revenue is recognized in the period when persuasive evidence of an arrangement with a customer exists, the products are shipped and title has transferred to the customer, the price is fixed or determinable, and collection is reasonably assured.
2
[ "<tag1>", "Product", "revenue", "is", "recognized", "in", "the", "period", "when", "persuasive", "evidence", "of", "an", "arrangement", "with", "a", "customer", "exists", ",", "the", "products", "are", "shipped", "and", "title", "has", "transferred", "to", "th...
[ "Product", "revenue", "is", "recognized", "in", "the", "period", "when", "persuasive", "evidence", "of", "an", "arrangement", "with", "a", "customer", "exists", ",", "the", "products", "are", "shipped", "and", "title", "has", "transferred", "to", "the", "custo...
[ "For", "product", "sales", "in", "the", "Energy", "segment", ",", "revenue", "is", "recognized", "in", "the", "period", "when", "persuasive", "evidence", "of", "an", "arrangement", "with", "a", "customer", "exists", ",", "the", "products", "are", "shipped", ...
[]
[ "product", "sales", "Energy", "segment" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1108967_16_item7_p102_s2
1108967_15_item7_p29_s1
A significant portion of this increased net loss is associated with equity compensation issued in the form of stock and options grants to strategic consultants, employees and directors for performance as well as vesting of granted stock options totaling approximately $1.7 million, an increase of approximately $1.1 mill...
A significant portion of the increase in non-cash related expense is the equity compensation issued in the form of stock and options grants to strategic consultants, employees and directors for performance as well as vesting of granted stock options totaling approximately $1.7 million, an increase of approximately $1.1...
2
[ "<tag1>", "A", "significant", "portion", "of", "this", "increased", "net", "loss", "is", "associated", "with", "equity", "compensation", "issued", "in", "the", "form", "of", "stock", "and", "options", "grants", "to", "strategic", "consultants", ",", "employees",...
[ "A", "significant", "portion", "of", "this", "increased", "net", "loss", "is", "associated", "with", "equity", "compensation", "issued", "in", "the", "form", "of", "stock", "and", "options", "grants", "to", "strategic", "consultants", ",", "employees", "and", ...
[ "A", "significant", "portion", "of", "the", "increase", "in", "non", "-", "cash", "related", "expense", "is", "the", "equity", "compensation", "issued", "in", "the", "form", "of", "stock", "and", "options", "grants", "to", "strategic", "consultants", ",", "e...
[]
[ "non", "cash", "related", "expense" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...
1108967_16_item7_p102_s5
1108967_15_item7_p29_s4
Of this increase, the Gas segment increased approximately $9.5 million related to having Orbital Gas Systems for the full year in 2014 as well as general sales growth for this segment.
Of this increase, the Energy segment increased approximately $9.5 million related to having Orbital for the full year in 2014 as well as general sales growth for this segment.
2
[ "<tag1>", "Of", "this", "increase", ",", "the", "Gas", "segment", "increased", "approximately", "$", "9.5", "million", "related", "to", "having", "Orbital", "Gas", "Systems", "for", "the", "full", "year", "in", "2014", "as", "well", "as", "general", "sales",...
[ "Of", "this", "increase", ",", "the", "Gas", "segment", "increased", "approximately", "$", "9.5", "million", "related", "to", "having", "Orbital", "Gas", "Systems", "for", "the", "full", "year", "in", "2014", "as", "well", "as", "general", "sales", "growth",...
[ "Of", "this", "increase", ",", "the", "Energy", "segment", "increased", "approximately", "$", "9.5", "million", "related", "to", "having", "Orbital", "for", "the", "full", "year", "in", "2014", "as", "well", "as", "general", "sales", "growth", "for", "this",...
[]
[ "Energy" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, 0, -10...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1108967_16_item7_p35_s4
1108967_15_item7_p29_s4
Of this increase, the Gas segment increased approximately $9.5 million related to having Orbital Gas Systems for the full year in 2014 as well as general sales growth for this segment.
Of this increase in revenues, the Energy segment increased approximately $9.5 million related to having Orbital for the full year in 2014 as well as general sales growth for this segment.
2
[ "<tag1>", "Of", "this", "increase", ",", "the", "Gas", "segment", "increased", "approximately", "$", "9.5", "million", "related", "to", "having", "Orbital", "Gas", "Systems", "for", "the", "full", "year", "in", "2014", "as", "well", "as", "general", "sales",...
[ "Of", "this", "increase", ",", "the", "Gas", "segment", "increased", "approximately", "$", "9.5", "million", "related", "to", "having", "Orbital", "Gas", "Systems", "for", "the", "full", "year", "in", "2014", "as", "well", "as", "general", "sales", "growth",...
[ "Of", "this", "increase", "in", "revenues", ",", "the", "Energy", "segment", "increased", "approximately", "$", "9.5", "million", "related", "to", "having", "Orbital", "for", "the", "full", "year", "in", "2014", "as", "well", "as", "general", "sales", "growt...
[]
[ "revenues", "Energy" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, 0, 1, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1108967_16_item7_p38_s1
1108967_15_item7_p31_s2
The improvement in the net loss, during the year ended December 31, 2013 as compared with 2012 is associated with the increase in revenues and related gross profits, both from the addition of Orbital Gas Systems Limited in April 2013 which contributed approximately $17.5 million of revenues during the last three quarte...
Revenues increased in 2013 both from the addition of Orbital in April 2013, which contributed approximately $17.5 million of revenues during the last three quarters of 2013 and the growth in the Power and Electromechanical segment of CUI, Inc. and CUI Japan, which had increased revenues over the prior year of approxima...
2
[ "<tag1>", "The", "improvement", "in", "the", "net", "loss", ",", "during", "the", "year", "ended", "December", "31", ",", "2013", "as", "compared", "with", "2012", "is", "associated", "with", "the", "increase", "in", "revenues", "and", "related", "gross", ...
[ "The", "improvement", "in", "the", "net", "loss", ",", "during", "the", "year", "ended", "December", "31", ",", "2013", "as", "compared", "with", "2012", "is", "associated", "with", "the", "increase", "in", "revenues", "and", "related", "gross", "profits", ...
[ "Revenues", "increased", "in", "2013", "both", "from", "the", "addition", "of", "Orbital", "in", "April", "2013", ",", "which", "contributed", "approximately", "$", "17.5", "million", "of", "revenues", "during", "the", "last", "three", "quarters", "of", "2013"...
[]
[ "Revenues", "Electromechanical" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...
1108967_16_item7_p39_s5
1108967_15_item7_p32_s5
Unearned revenue and billings in excess of costs increased during the period, these are associated with several customer prepayments and deferred revenues including on certain power and electro-mechanical product sales through distribution.
These are associated with several customer prepayments and deferred revenues including on certain power and electromechanical product sales through distribution.
2
[ "<tag1>", "Unearned", "revenue", "and", "billings", "in", "excess", "of", "costs", "increased", "during", "the", "period", ",", "these", "are", "associated", "with", "several", "customer", "prepayments", "and", "deferred", "revenues", "including", "on", "certain",...
[ "Unearned", "revenue", "and", "billings", "in", "excess", "of", "costs", "increased", "during", "the", "period", ",", "these", "are", "associated", "with", "several", "customer", "prepayments", "and", "deferred", "revenues", "including", "on", "certain", "power", ...
[ "These", "are", "associated", "with", "several", "customer", "prepayments", "and", "deferred", "revenues", "including", "on", "certain", "power", "and", "electromechanical", "product", "sales", "through", "distribution", "." ]
[]
[ "electromechanical" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]
1108967_16_item7_p42_s3
1108967_15_item7_p37_s2
The 2013 investments in property and equipment included the down payment toward the September 2013 acquisition of the headquarters facility, which is discussed below in Investing Activities related party activity .
The 2013 investments in property and equipment included the down payment toward the September 2013 acquisition of the headquarters facility in Tualatin, Oregon, which is discussed below in Investing Activities related party activity .
2
[ "<tag1>", "The", "2013", "investments", "in", "property", "and", "equipment", "included", "the", "down", "payment", "toward", "the", "September", "2013", "acquisition", "of", "the", "headquarters", "facility", ",", "which", "is", "discussed", "below", "in", "Inv...
[ "The", "2013", "investments", "in", "property", "and", "equipment", "included", "the", "down", "payment", "toward", "the", "September", "2013", "acquisition", "of", "the", "headquarters", "facility", ",", "which", "is", "discussed", "below", "in", "Investing", "...
[ "The", "2013", "investments", "in", "property", "and", "equipment", "included", "the", "down", "payment", "toward", "the", "September", "2013", "acquisition", "of", "the", "headquarters", "facility", "in", "Tualatin", ",", "Oregon", ",", "which", "is", "discusse...
[]
[ "Tualatin", "Oregon" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, 0, 0, -100, -100, -100, -100, ...
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...
1108967_16_item7_p48_s4
1108967_15_item7_p43_s4
The cash paid upon acquisition, net of cash received was $17,709,507.
The cash paid upon acquisition, net of cash received was $17.7 million.
2
[ "<tag1>", "The", "cash", "paid", "upon", "acquisition", ",", "net", "of", "cash", "received", "was", "$", "17,709,507", ".", "<tag2>", "The", "cash", "paid", "upon", "acquisition", ",", "net", "of", "cash", "received", "was", "$", "17.7", "million", ".", ...
[ "The", "cash", "paid", "upon", "acquisition", ",", "net", "of", "cash", "received", "was", "$", "17,709,507", "." ]
[ "The", "cash", "paid", "upon", "acquisition", ",", "net", "of", "cash", "received", "was", "$", "17.7", "million", "." ]
[]
[ "17.7", "million" ]
[ -1, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -1, -100, -100, -100, 0, 0, -100, -100, -100, 0, 0, 0, 0, 1, 1, -100, -1 ]
[ -1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1 ]